<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hbm70171" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Brain Mapp</journal-id><journal-id journal-id-type="iso-abbrev">Hum Brain Mapp</journal-id><journal-id journal-id-type="pmc-domain-id">3754</journal-id><journal-id journal-id-type="pmc-domain">humanbrain</journal-id><journal-id journal-id-type="publisher-id">HBM</journal-id><journal-title-group><journal-title>Human Brain Mapping</journal-title></journal-title-group><issn pub-type="ppub">1065-9471</issn><issn pub-type="epub">1097-0193</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11867789</article-id><article-id pub-id-type="pmcid-ver">PMC11867789.1</article-id><article-id pub-id-type="pmcaid">11867789</article-id><article-id pub-id-type="pmcaiid">11867789</article-id><article-id pub-id-type="pmid">40016624</article-id><article-id pub-id-type="doi">10.1002/hbm.70171</article-id><article-id pub-id-type="publisher-id">HBM70171</article-id><article-id pub-id-type="other">HBM-24-1218.R1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association Between Single Nucleotide Polymorphisms in the Aquaporin‐4 Gene and Longitudinal Changes in White Matter Free Water and Cognitive Function in Non‐Demented Older Adults</article-title></title-group><contrib-group><contrib id="hbm70171-cr-0001" contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="L">Lingyun</given-names></name><xref rid="hbm70171-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0002" contrib-type="author"><name name-style="western"><surname>Zeng</surname><given-names initials="Q">Qingze</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0003" contrib-type="author"><name name-style="western"><surname>Luo</surname><given-names initials="X">Xiao</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0004" contrib-type="author"><name name-style="western"><surname>Hong</surname><given-names initials="H">Hui</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0005" contrib-type="author"><name name-style="western"><surname>Fang</surname><given-names initials="Y">Yi</given-names></name><xref rid="hbm70171-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hbm70171-cr-0006" contrib-type="author"><name name-style="western"><surname>Xie</surname><given-names initials="L">Linyun</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0007" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Yao</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0008" contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="M">Miao</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0009" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="S">Shuyue</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0010" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="K">Kaicheng</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0011" contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="X">Xiaocao</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0012" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="R">Ruiting</given-names></name><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm70171-cr-0013" contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Yanxing</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8571-2802</contrib-id><xref rid="hbm70171-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hbm70171-cr-0014" contrib-type="author" corresp="yes"><name name-style="western"><surname>Yang</surname><given-names initials="Y">Yunjun</given-names></name><xref rid="hbm70171-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>yyjunjim@163.com</email></address></contrib><contrib id="hbm70171-cr-0015" contrib-type="author" corresp="yes"><name name-style="western"><surname>Huang</surname><given-names initials="P">Peiyu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4226-9369</contrib-id><xref rid="hbm70171-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="hbm70171-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>huangpy@zju.edu.cn</email></address></contrib></contrib-group><aff id="hbm70171-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>The First Affiliated Hospital of Wenzhou Medical University</institution>
<city>Wenzhou</city>
<country country="CN">China</country>
</aff><aff id="hbm70171-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>The Second Affiliated Hospital of Zhejiang University School of Medicine</institution>
<city>Hangzhou</city>
<country country="CN">China</country>
</aff><aff id="hbm70171-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>The Second Affiliated Hospital of Zhejiang University School of Medicine</institution>
<city>Hangzhou</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><break/>
Yunjun Yang (<email>yyjunjim@163.com</email>)<break/>
Peiyu Huang (<email>huangpy@zju.edu.cn</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2025</year></pub-date><volume>46</volume><issue seq="30">4</issue><issue-id pub-id-type="pmc-issue-id">483123</issue-id><issue-id pub-id-type="doi">10.1002/hbm.v46.4</issue-id><elocation-id>e70171</elocation-id><history><date date-type="rev-recd"><day>19</day><month>1</month><year>2025</year></date><date date-type="received"><day>24</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-04 20:25:38.220"><day>04</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">© 2025 The Author(s). <italic toggle="yes">Human Brain Mapping</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="HBM-46-e70171.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:HBM-46-e70171.pdf"/><abstract><title>ABSTRACT</title><p>We investigated whether aquaporin‐4 (AQP4) single‐nucleotide polymorphisms (SNPs) influence Alzheimer's disease (AD) progression through changes in the glymphatic system. We included 242 non‐dementia participants and chose six SNPs previously shown to be related to AD. We analyzed the associations between AQP4 SNPs and glymphatic markers, including enlarged perivascular spaces (PVS), white matter free water (FW), and diffusion tensor image analysis along the perivascular space (DTI‐ALPS), in both cross‐sectional and longitudinal data. We investigated whether AQP4‐related glymphatic markers are associated with AD pathology progression and cognitive impairment, and whether they mediate the relationship between AQP4 SNPs and AD progression. There was no association between AQP4 SNPs and glymphatic markers at baseline. Carriers of the AQP4 SNP rs72878794 minor allele status exhibited slower FW increase in the amyloid‐positive group (SNP*time: <italic toggle="no">β</italic> = −0.0040, t(46.25) = −2.062, <italic toggle="no">p</italic> = 0.045, 95% CI = −0.0078 ~ −0.0001), whereas the rs9951307 minor allele carrier showed a faster FW increase in the amyloid‐negative group (SNP*time: <italic toggle="no">β</italic> =0.0033, t(81.19) = 2.245, <italic toggle="no">p</italic> = 0.027, 95% CI = 0.0004 ~ 0.0062). The higher FW was associated with faster cognitive decline at follow‐ups. AQP4 SNPs influence interstitial fluid accumulation, contributing to cognitive decline but not amyloid deposition in AD. Further studies are needed to clarify the pathways linking AQP4 SNPs and AD progression.</p></abstract><abstract abstract-type="graphical"><p>AQP4 SNPs are related to the deposition of AD pathology and the changes in cognition. One possible mechanism for these relationships may be clearance disorders of the glymphatic system. This study used three imaging indicators to explore this mechanism. We found that the rs72878794 was associated with a slower increase in FW. However, the rs9951307 was associated with a faster increase.<boxed-text position="anchor" content-type="graphic" id="hbm70171-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="HBM-46-e70171-g002.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="hbm70171-kwd-0001">Alzheimer's disease</kwd><kwd id="hbm70171-kwd-0002">aquaporin‐4</kwd><kwd id="hbm70171-kwd-0003">glymphatic system</kwd><kwd id="hbm70171-kwd-0004">magnetic resonance imaging</kwd><kwd id="hbm70171-kwd-0005">single‐nucleotide polymorphisms</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Natural Science Foundation of Zhejiang Province
</institution><institution-id institution-id-type="doi">10.13039/501100004731</institution-id></institution-wrap></funding-source><award-id>LZ24H180002</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82371907</award-id><award-id>82101987</award-id><award-id>82202090</award-id><award-id>82271936</award-id><award-id>82371190</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="13"/><word-count count="8600"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="hbm70171-ntgp-0001"><fn fn-type="funding" id="hbm70171-note-0001"><p>
<bold>Funding:</bold> This work was supported by Natural Science Foundation of Zhejiang Province, LZ24H180002, National Natural Science Foundation of China, 82371907, 82101987, 82202090, 82271936, 82371190.</p></fn><fn fn-type="equal" id="hbm70171-note-0002"><p>Lingyun Liu and Qingze Zeng contributed equally to this work.</p></fn></fn-group></notes></front><body id="hbm70171-body-0001"><def-list list-content="abbreviations" id="hbm70171-dl-0001"><title>Abbreviations</title><def-item><term id="hbm70171-li-0001">AD</term><def id="hbm70171-li-0002"><p>Alzheimer's disease</p></def></def-item><def-item><term id="hbm70171-li-0003">APOE</term><def id="hbm70171-li-0004"><p>Apolipoprotein</p></def></def-item><def-item><term id="hbm70171-li-0005">AQP4</term><def id="hbm70171-li-0006"><p>Aquaporin‐4</p></def></def-item><def-item><term id="hbm70171-li-0007">Aβ</term><def id="hbm70171-li-0008"><p>Amyloid‐beta</p></def></def-item><def-item><term id="hbm70171-li-0009">BG</term><def id="hbm70171-li-0010"><p>Basal ganglia</p></def></def-item><def-item><term id="hbm70171-li-0011">CDR</term><def id="hbm70171-li-0012"><p>Clinical Dementia Rating</p></def></def-item><def-item><term id="hbm70171-li-0013">CSF</term><def id="hbm70171-li-0014"><p>Cerebrospinal fluid</p></def></def-item><def-item><term id="hbm70171-li-0015">CU</term><def id="hbm70171-li-0016"><p>Cognitively unimpaired</p></def></def-item><def-item><term id="hbm70171-li-0017">DCE‐MRI</term><def id="hbm70171-li-0018"><p>Dynamic contrast‐enhanced magnetic resonance imaging</p></def></def-item><def-item><term id="hbm70171-li-0019">DTI</term><def id="hbm70171-li-0020"><p>Diffusion tensor image</p></def></def-item><def-item><term id="hbm70171-li-0021">DTI‐ALPS</term><def id="hbm70171-li-0022"><p>Diffusion tensor imaging analysis along the perivascular space</p></def></def-item><def-item><term id="hbm70171-li-0023">FW</term><def id="hbm70171-li-0024"><p>Free water</p></def></def-item><def-item><term id="hbm70171-li-0025">ISF</term><def id="hbm70171-li-0026"><p>Interstitial fluid</p></def></def-item><def-item><term id="hbm70171-li-0027">MCI</term><def id="hbm70171-li-0028"><p>Cognitive impairment</p></def></def-item><def-item><term id="hbm70171-li-0029">MMSE</term><def id="hbm70171-li-0030"><p>Mini‐Mental State Examination</p></def></def-item><def-item><term id="hbm70171-li-0031">MoCA</term><def id="hbm70171-li-0032"><p>Montreal Cognitive Assessment</p></def></def-item><def-item><term id="hbm70171-li-0033">MRI</term><def id="hbm70171-li-0034"><p>Magnetic resonance imaging</p></def></def-item><def-item><term id="hbm70171-li-0035">PVS</term><def id="hbm70171-li-0036"><p>Perivascular spaces</p></def></def-item><def-item><term id="hbm70171-li-0037">SNP</term><def id="hbm70171-li-0038"><p>Single‐nucleotide polymorphisms</p></def></def-item><def-item><term id="hbm70171-li-0039">TMT‐A</term><def id="hbm70171-li-0040"><p>Trial‐Making Test‐A</p></def></def-item><def-item><term id="hbm70171-li-0041">TMT‐B</term><def id="hbm70171-li-0042"><p>Trial‐Making Test‐B</p></def></def-item></def-list><sec sec-type="background" id="hbm70171-sec-0001"><label>1</label><title>Background</title><p>The glymphatic system has been described as a “garbage truck” of the human brain (Nedergaard <xref rid="hbm70171-bib-0025" ref-type="bibr">2013</xref>). Studies demonstrated that cerebrospinal fluid (CSF) can flow into the perivascular spaces (PVS) surrounding penetrating arteries and enter the brain interstitial space through aquaporin‐4 (AQP4) water channels located on the endfeet of astroglial cells, where CSF and interstitial fluid (ISF) mix and efflux, taking away brain metabolic wastes (Benveniste et al. <xref rid="hbm70171-bib-0001" ref-type="bibr">2017</xref>; Iliff et al. <xref rid="hbm70171-bib-0016" ref-type="bibr">2012</xref>; Nedergaard and Goldman <xref rid="hbm70171-bib-0026" ref-type="bibr">2020</xref>). Impairment of the glymphatic system may lead to the accumulation of pathological proteins, such as amyloid‐beta (Aβ) and tau (Tiwari et al. <xref rid="hbm70171-bib-0039" ref-type="bibr">2019</xref>), the core pathologies of Alzheimer's disease (AD) (Keshavan et al. <xref rid="hbm70171-bib-0019" ref-type="bibr">2021</xref>), and contribute to the development of various neurological disorders (Fang et al. <xref rid="hbm70171-bib-0007" ref-type="bibr">2022</xref>; Vittorini et al. <xref rid="hbm70171-bib-0042" ref-type="bibr">2024</xref>).</p><p>Along the glymphatic pathway, the AQP4 channels are a crucial component (Mestre et al. <xref rid="hbm70171-bib-0023" ref-type="bibr">2018</xref>). They form abundant pores in the cell membrane, creating a high permeability that is essential for the rapid CSF –ISF exchange and waste clearance (Rasmussen et al. <xref rid="hbm70171-bib-0032" ref-type="bibr">2018</xref>); Zeppenfeld et al. (<xref rid="hbm70171-bib-0044" ref-type="bibr">2017</xref>). Utilized brain autopsy data from non‐AD and AD patients and found that the loss of perivascular AQP4 localization was associated with an increased amyloid burden. Through stereotactic injection of HiLyte 555 Tau into the brain of AQP4 KO mice, Ishida et al. (Ishida et al. <xref rid="hbm70171-bib-0017" ref-type="bibr">2022</xref>) found that tau was cleared from the brain to the CSF by an AQP4‐dependent mechanism. Interestingly, single‐nucleotide polymorphisms (SNPs) in the AQP4 gene may alter the functionality of AQP4 proteins and influence glymphatic function. Several recent studies found that variations in the AQP4 gene might accelerate Aβ deposition and cognitive decline in humans (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>; Chandra et al. <xref rid="hbm70171-bib-0004" ref-type="bibr">2021</xref>; Rainey‐Smith et al. <xref rid="hbm70171-bib-0031" ref-type="bibr">2018</xref>). Nonetheless, there is a lack of human studies validating whether an altered glymphatic function mediates the association between gene variations and AD progression. Because AQP4 is also related to many other water exchange processes and degeneration mechanisms (Saadoun et al. <xref rid="hbm70171-bib-0034" ref-type="bibr">2005</xref>; Verkman <xref rid="hbm70171-bib-0041" ref-type="bibr">2012</xref>), clarifying the role of glymphatic clearance is necessary.</p><p>Currently, a few non‐invasive magnetic resonance imaging (MRI) markers are considered to be related to glymphatic alterations. First, dilation of PVS, the main conduit of glymphatic flow, has been found to be associated with aging, hypertension, Aβ, and a variety of neurodegenerative disorders (Zeng et al. <xref rid="hbm70171-bib-0043" ref-type="bibr">2022</xref>). The dilation was considered a compensatory restructuring of PVS in response to reduced glymphatic flow (Brown et al. <xref rid="hbm70171-bib-0002" ref-type="bibr">2018</xref>). Second, interstitial water content assessed by free water (FW) imaging may reflect fluid stagnation due to glymphatic dysfunction. A previous study (Gomolka et al. <xref rid="hbm70171-bib-0009" ref-type="bibr">2023</xref>) found increased parenchymal water diffusivity in mice with AQP4 water channel deletion, supporting the association between parenchymal water content measured by MRI and glymphatic dysfunction. Third, diffusion tensor image analysis along the perivascular space (DTI‐ALPS) (Taoka et al. <xref rid="hbm70171-bib-0037" ref-type="bibr">2017</xref>), an index measuring fluid transport in the perivenous space along the deep medullary veins, has demonstrated a good association with glymphatic clearance measured by DCE‐MRI (Zhang, Huang, et al. <xref rid="hbm70171-bib-0045" ref-type="bibr">2021</xref>; Zhang, Zhou, et al. <xref rid="hbm70171-bib-0046" ref-type="bibr">2021</xref>). While there are still debates regarding whether they could reflect global glymphatic function, these markers have been chosen due to the paucity of available MRI markers. Several previous studies have demonstrated their close association with clinical status and pathological deposition (Hong et al. <xref rid="hbm70171-bib-0011" ref-type="bibr">2024</xref>; Kamagata et al. <xref rid="hbm70171-bib-0018" ref-type="bibr">2022</xref>; Perosa et al. <xref rid="hbm70171-bib-0029" ref-type="bibr">2022</xref>).</p><p>In the present study, we aim to study whether AQP4 SNPs are associated with glymphatic function and clinical progression in non‐demented older adults. Specifically, we aim to study (1) the association between AQP4 SNPs and glymphatic markers through both cross‐sectional and longitudinal analyses and (2) whether changes in glymphatic markers mediate the association between AQP4 SNPs and AD progression.</p></sec><sec sec-type="materials-and-methods" id="hbm70171-sec-0002"><label>2</label><title>Materials and Methods</title><p>All procedures conducted in studies involving human participants adhered to the ethical standards set forth by the Institutional and National Research Committees, as well as the 1964 Declaration of Helsinki and its subsequent amendments or equivalent ethical guidelines. Written informed consent was obtained from all participants, their authorized representatives, and study partners prior to the initiation of any protocol‐specific procedures in the ADNI study. All data were downloaded at September 2023 from ADNI 2 &amp;3. Further information is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.adni-info.org" ext-link-type="uri">http://www.adni‐info.org</ext-link>.</p><sec id="hbm70171-sec-0003"><label>2.1</label><title>Study Participants</title><p>The inclusion criteria included (1) non‐demented participants, including cognitively unimpaired participants (CU, <italic toggle="yes">N</italic> = 126) and mild cognitive impairment participants (MCI, <italic toggle="yes">N</italic> = 116). The diagnoses were made by neurologists at admission. The CUs were defined as subjects who had a Clinical Dementia Rating (CDR) scale score of 0, a Mini‐Mental State Examination (MMSE) between 24 and 30 (inclusive), Wechsler memory scale logical memory (WMS‐LM) delay recall performance ≥ 9 for subjects with 16 or more years of education; ≥ 5 for subjects with 8–15 years of education; and ≥ 3 for 0–7 years of education; non‐clinical depression (GDS‐15 score &lt; 6), and absence of dementia. MCI was defined as subjects who had preserved activities of daily living, non‐dementia, and objective cognitive impairments, as shown on the delayed recall test of the WMS‐LM, as well as a CDR score of 0.5(2) with available T1‐weighted structural images, diffusion tensor imaging (DTI) images, and Aβ PET data; (3) with gene sequencing information; and (4) with neuropsychological assessments. Exclusion criteria were as follows (Li et al. <xref rid="hbm70171-bib-0021" ref-type="bibr">2023</xref>): (1) significant medical, neurological, and psychiatric illness, (2) head trauma history, (3) use of non‐AD‐related medication known to influence cerebral function, and (4) alcohol or drug abuse.</p><p>To ensure the maximum sample size, for participants with multiple follow‐up timepoints, we considered the first timepoint that met all inclusion criteria as the baseline timepoint. Available follow‐up data (varied from 0 to 10.25 years) were also collected (see flowchart in Figure <xref rid="hbm70171-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="FIGURE" id="hbm70171-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Flowchart of the subject inclusion: 242 non‐demented participants were included for analyses, listing the number of subjects with 2, 3, 4, or 5 visits for each modality. For the cutoffs of brain amyloid, participants were categorized as Aβ positive (A+) and Aβ negative (A−). ADNI, Alzheimer's disease neuroimaging initiative; DTI, diffusion tensor imaging; FBB, [18F] florbetaben; FBP, [18F] florbetapir; PET, positron emission tomography.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="HBM-46-e70171-g003.jpg"/></fig><p>Vascular risk factor score (VRFs), including hypertension, diabetes, hyperlipidemia, and smoking, was recorded based on participants' medical history. Each factor was coded as 0 (absent) or 1 (present), resulting in a total score ranging from 0 to 4.</p></sec><sec id="hbm70171-sec-0004"><label>2.2</label><title>Neuropsychological Assessment</title><p>Primary measures were global cognitive function, episodic memory, and executive function. Global cognition assessments (Oh et al. <xref rid="hbm70171-bib-0027" ref-type="bibr">2021</xref>) included the MMSE, Montreal Cognitive Assessment (MoCA), and CDR (Tsang et al. <xref rid="hbm70171-bib-0040" ref-type="bibr">2015</xref>). Logical Memory‐Delayed Recall (Tedeschi Dauar et al. <xref rid="hbm70171-bib-0038" ref-type="bibr">2023</xref>) was used to assess episodic memory. The Trails Making Test Part A and Part B (TMT‐A and TMT‐B) (Dikmen et al. <xref rid="hbm70171-bib-0005" ref-type="bibr">1999</xref>) were used to assess executive function.</p></sec><sec id="hbm70171-sec-0005"><label>2.3</label><title>Genetic Analysis</title><p>Participants carrying at least one apolipoprotein (APOE) ε4 allele were classified as carriers, while the rest were categorized as noncarriers. Whole‐genome sequencing data were downloaded from the ADNI database. To store statistically relevant SNPs called using Illumina's CASAVA SNP Caller, the ADNI WGS SNP data are stored in variant call format (VCF). SNP pruning was undertaken using PLINK (Purcell et al. <xref rid="hbm70171-bib-0030" ref-type="bibr">2007</xref>). Genetic variants of AQP4 underwent quality control procedures. Specifically, we removed the SNPs that were not in Hardy–Weinberg equilibrium (<italic toggle="yes">p</italic> &lt; 0.05) (Hosking et al. <xref rid="hbm70171-bib-0013" ref-type="bibr">2004</xref>) and had a minor allele frequency of &lt; 5% (Tabangin et al. <xref rid="hbm70171-bib-0036" ref-type="bibr">2009</xref>). Linkage disequilibrium‐based SNP pruning (Hill and Robertson <xref rid="hbm70171-bib-0010" ref-type="bibr">1968</xref>) was performed to reduce statistical redundancy and maintain coverage of the AQP4 gene. From the rest of the SNPs, six SNPs that had been shown to be clinically relevant in AD were chosen. The results are shown in Figure <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S1</xref>. The information on these SNPs is displayed in Table <xref rid="hbm70171-tbl-0001" ref-type="table">1</xref> and Figure <xref rid="hbm70171-fig-0002" ref-type="fig">2</xref>. Participants possessing one or two copies of the minor allele were classified as “carriers” for the SNP. Details were provided in the <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>.</p><table-wrap position="float" id="hbm70171-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>AQP4 SNPs included in this study.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Annotation</th><th align="center" valign="bottom" rowspan="1" colspan="1">Position (GRCh38)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Minor allele frequency</th><th align="center" valign="bottom" rowspan="1" colspan="1">Previously reported associations</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">rs9951307 G/A</td><td align="center" valign="top" rowspan="1" colspan="1">downstream</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26850565</td><td align="center" valign="top" rowspan="1" colspan="1">0.172</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763043 C/T</td><td align="center" valign="top" rowspan="1" colspan="1">3’‐UTR</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26855854</td><td align="center" valign="top" rowspan="1" colspan="1">0.318</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763040 G/A</td><td align="center" valign="top" rowspan="1" colspan="1">Exon 1 promoter</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26864410</td><td align="center" valign="top" rowspan="1" colspan="1">0.192</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3875089 T/C</td><td align="center" valign="top" rowspan="1" colspan="1">Exon 1 promoter</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26865469</td><td align="center" valign="top" rowspan="1" colspan="1">0.149</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs151244 T/C</td><td align="center" valign="top" rowspan="1" colspan="1">Exon 0 promoter</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26866755</td><td align="center" valign="top" rowspan="1" colspan="1">0.294</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Chandra et al. <xref rid="hbm70171-bib-0004" ref-type="bibr">2021</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs72878794 C/T</td><td align="center" valign="top" rowspan="1" colspan="1">Exon 0 promoter</td><td align="center" valign="top" rowspan="1" colspan="1">chr18:26866839</td><td align="center" valign="top" rowspan="1" colspan="1">0.038</td><td align="center" valign="top" rowspan="1" colspan="1">Cognitive decline in AD (Chandra et al. <xref rid="hbm70171-bib-0004" ref-type="bibr">2021</xref>)</td></tr></tbody></table></table-wrap><fig position="float" fig-type="FIGURE" id="hbm70171-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Schematic illustration of the investigated SNPs in the AQP4 gene. There are two isoforms of AQP4: M1 and M23. M1 consists of exon 0–4, and M23 consists of exon 1–4.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="HBM-46-e70171-g001.jpg"/></fig></sec><sec id="hbm70171-sec-0006"><label>2.4</label><title>Imaging Acquisition</title><p>The ADNI imaging data were acquired from different centers using harmonized protocols, and the full list of acquisition parameters can be seen on the ADNI website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://adni.loni.usc.edu/methods/documents/mri-protocols/" ext-link-type="uri">https://adni.loni.usc.edu/methods/documents/mri‐protocols/</ext-link>). All imaging data were acquired using 3 T scanners from three vendors (GE, Siemens, and Philips). Here, we list some representative imaging parameters:</p><p>The structural images were obtained based on a 3D Spoiled Gradient Recalled Echo T1 weighted sequence, with the following parameters: Flip Angle = 11°; Matrix <italic toggle="yes">X</italic> = 256 pixels; Matrix Y = 256 pixels; voxel size = 1 × 1 × 1.2 mm<sup>3</sup>; echo time (TE) = minimum; inversion time (TI) = 400 msec; repetition time (TR) = 7.34 msec; 196 sagittal slices. The axial T2 FLAIR sequence used the following parameters: Flip Angle = 90.0/125.0°; Matrix <italic toggle="yes">X</italic> = 256 pixels; Matrix <italic toggle="yes">Y</italic> = 256 pixels; voxel size = 0.9 × 0.9 × 5.0 mm<sup>3</sup>; TE = 147.9–154.0 msec; TI = 2250.0 msec; TR = 11000.0 msec. DTI images were obtained with a Spin Echo Sequence using the following imaging parameters: b = 0/1000 s/mm<sup>2</sup>, non‐diffusion‐weighted image = 5, 41 MPG axes, TR = 9050 msec, TE = 63.0 msec, flip angle of 90°, 1.37 mm × 1.37 mm voxel, 2.70 slice thickness, and 46 axial slices.</p><p>The amyloid PET was performed using two tracers, including florbetapir or florbetaben. The detailed acquisition procedures were described in the ADNI PET Technical Procedures Manual (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu/wp-content/uploads/2010/05/ADNI2_PET_Tech_Manual_0142011.pdf" ext-link-type="uri">http://adni.loni.usc.edu/wp‐content/uploads/2010/05/ADNI2_PET_Tech_Manual_0142011.pdf</ext-link>). For the cutoffs of brain amyloid, the values were 1.11 for 18F‐florbetapir (18[F]‐AV45) SUVR and 1.08 for 18F‐florbetaben (FBB) SUVR (Royse et al. <xref rid="hbm70171-bib-0033" ref-type="bibr">2021</xref>); according to the cutoff, participants were categorized as Aβ positive (A+) and Aβ negative (A−). For continuous brain amyloid SUVR, cortical amyloid SUVRs obtained from different PET tracers were harmonized by UC Berkeley and Lawrence Berkeley National Laboratory. These SUVRs were normalized using the whole cerebellum and then transformed into Centiloids.</p></sec><sec id="hbm70171-sec-0007"><label>2.5</label><title>Imaging Analysis</title><sec id="hbm70171-sec-0008"><label>2.5.1</label><title>
<styled-content style="fixed-case" toggle="no">PVS</styled-content> Visual Rating</title><p>PVS in the basal ganglia (BG) and white matter (WM) region were assessed on T1‐weighted images by two postgraduate students (LX; LL) according to a previously proposed rating scale (Zhu et al. <xref rid="hbm70171-bib-0047" ref-type="bibr">2011</xref>). Briefly, in the BG region, PVS was rated 1: &lt; 5 enlarged PVS (ePVS), rated 2: 5–10 ePVS, rated 3: &gt; 10 ePVS but the number is still countable, and rated 4: uncountable; in the WM region, PVS severity was rated 1: &lt; 10 ePVS in total, rated 2: &gt; 10 PVS in total but no more than 10 ePVS in a single section, rated 3: 10–20 ePVS in the section containing the greatest number of ePVS, and rated 4: &gt; 20 ePVS in any single section.</p></sec><sec id="hbm70171-sec-0009"><label>2.5.2</label><title>
<styled-content style="fixed-case" toggle="no">DTI</styled-content>‐<styled-content style="fixed-case" toggle="no">ALPS</styled-content> Calculation</title><p>The processing of DTI data was conducted using FSL 6.0 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl" ext-link-type="uri">https://fsl.fmrib.ox.ac.uk/fsl</ext-link>). The preprocessing steps included skull stripping, denoising, removing Gibbs artifact, EPI distortion correction, and eddy current correction.</p><p>DTI‐ALPS was calculated referring to the previous article (Taoka et al. <xref rid="hbm70171-bib-0037" ref-type="bibr">2017</xref>). Briefly, the FA maps and diffusivity maps [Dxx, Dyy, Dzz] were acquired from preprocessed diffusion data using dtifit and then co‐registered to the MNI space through b0 images. Four cross‐regions of interest (ROIs) containing five voxels (40 mm<sup>3</sup>) were manually placed in the areas of bilateral projection fiber (proj) and association fiber. The left and right ALPS index was calculated as [(Dxx‐proj + Dxx‐assoc) / (Dyy‐proj + Dzz‐assoc)] on each side, respectively. The mean ALPS index is defined by the average of bilateral ALPS indexes.</p></sec><sec id="hbm70171-sec-0010"><label>2.5.3</label><title>
<styled-content style="fixed-case" toggle="no">FW</styled-content> Calculation</title><p>The FW map was calculated using the script from the MarkVCID (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://markvcid.partners.org/" ext-link-type="uri">https://markvcid.partners.org/</ext-link>). The MarkVCID is a consortium of US academic medical centers. Its mission is to identify and validate biomarkers for the small vessel diseases of the brain that produce vascular contributions to cognitive impairment and dementia. FW was estimated using a two‐compartment model (Pasternak et al. <xref rid="hbm70171-bib-0028" ref-type="bibr">2009</xref>) by fitting the diffusion data of water molecules to two tensors. First, the extracellular FW was quantified to obtain the isotropic FW compartment and the FW volume fraction. Second, after removing the influence of FW, the anisotropic tissue compartment was obtained through the second DTI modeling to obtain the DTI index after the correction of FW separation. The FW map represents the fractional volume in every voxel (ranging from 0 to 1) of the FW compartment. Finally, the generated FW maps were registered to structural images through b0 images, and the mean FW in the WM was extracted.</p></sec><sec id="hbm70171-sec-0011"><label>2.5.4</label><title>Statistical Analysis</title><p>All the statistical analyses were performed in R (version 4.3.0) and SPSS Statistics, Version 25.0 (IBM). Demographic characteristics between groups were compared using the <italic toggle="yes">t</italic>‐test for normally distributed continuous variables, the Mann–Whitney U test for non‐normally distributed continuous variables, and chi‐square tests for categorical variables. To reduce site effects, we conducted multicenter data harmonization on diffusion metrics FW and DTI‐ALPS using the COMBAT method with age and sex included as biological variables (Fortin et al. <xref rid="hbm70171-bib-0008" ref-type="bibr">2017</xref>). To remove possible influences of WM microstructural properties on DTI‐ALPS assessment (Huang et al. <xref rid="hbm70171-bib-0015" ref-type="bibr">2024</xref>), we also included the whole brain WM mean diffusivity (MD) as a covariate in the analyses involving the DTI‐ALPS index. All analyses were performed in the whole group, the A + group, and the A− group separately.</p></sec><sec id="hbm70171-sec-0012"><label>2.5.5</label><title>Correlation Among the Three Imaging Markers</title><p>First, we tested the correlations among the three imaging markers. Pearson correlation was used to investigate the correlation between FW and DTI‐ALPS, and Spearman's correlation was used to investigate the correlation between FW\DTI‐ALPS and PVS scores.</p></sec><sec id="hbm70171-sec-0013"><label>2.5.6</label><title>The Association Between <styled-content style="fixed-case" toggle="no">AQP4 SNPS</styled-content> and Glymphatic Markers</title><p>For baseline cross‐sectional analysis, multiple linear regression analysis was used to assess the associations between AQP4 SNPs and glymphatic markers, with age, sex, and VRFs as covariates.</p><p>
<italic toggle="yes">Model1: glymphatic marker ~ SNP1 + … + SNP6 + age + sex + VRFs</italic>.</p><p>For the association between AQP4 SNPs and longitudinal changes in each glymphatic marker, linear mixed models (lme4, R statistics) were employed, with AQP4 SNPs and their interactions with time as independent variables and each glymphatic marker as the dependent variable. Age, sex, and VRFs were introduced as covariates.</p><p>
<italic toggle="yes">Model2: glymphatic marker ~ SNP1 × time + … + SNP6 × time + SNP1 + … + SNP6 + time + age + sex + VRFs + (1 + time | Subject)</italic>.</p></sec><sec id="hbm70171-sec-0014"><label>2.5.7</label><title>The Association Between the <styled-content style="fixed-case" toggle="no">AQP4 SNP</styled-content>‐Related Glymphatic Marker and Clinical Characteristics</title><p>For baseline cross‐sectional analysis, multiple linear regression analysis was used to assess the associations between the AQP4 SNP‐related glymphatic marker (i.e., FW) and amyloid accumulation and cognitive performance. When analyzing the association between FW and amyloid accumulation, age, sex, VRFs, and the status of APOE ε4 carriers were included as covariates. When analyzing the association between FW and cognitive performance, education was additionally added as a covariate. The equations for each model were as follows:</p><p>
<italic toggle="yes">Model3: Amyloid PET Centiloids ~ FW + age + sex + VRFs + APOE ε4</italic>.</p><p>
<italic toggle="yes">Model4: cognitive measure ~ FW + age + sex + VRFs + APOE ε4 + education</italic>.</p><p>Linear mixed models were also employed to investigate the association between baseline FW and changes in amyloid accumulation and cognition. When analyzing the association between baseline FW and changes in amyloid accumulation, age, sex, VRFs, and APOE ε4 status were included as covariates. When analyzing the association between baseline FW and the changes in cognition, education was additionally included as a covariate.</p><p>
<italic toggle="yes">Model5: Amyloid PET Centiloids ~ FW × time + FW + time + age + sex + VRFs + APOE ε4 + (1 + time | Subject)</italic>.</p><p>
<italic toggle="yes">Model6: cognitive measure ~ FW × time + FW + time + age + sex + VRFs + education + APOE ε4 + (1 + time | Subject)</italic>.</p></sec><sec id="hbm70171-sec-0015"><label>2.5.8</label><title>Mediation Analyses</title><p>After the previous steps, we found associations between the SNPs, FW, and cognitive measures. To test whether FW mediated the associations between SNPs and cognitive measures, we built several mediation models (Figures <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S2–S6</xref>). In the Aβ positive group: (1) SNP rs72878794 → FW → CDR ratio, (2) SNP rs72878794 → FW → Logical Memory‐Delayed Recall score ratio, and (3) SNP rs72878794 → FW → TMT‐A time ratio. In the Aβ negative group: (1) SNP rs9951307 → FW → CDR ratio, and (2) SNP rs9951307 → FW → TMT‐A time ratio.</p><p>Specifically, we used linear mixed models to extract the annual change ratio of FW and cognitive measures and used the R “Mediation” package to build and analyze the mediation model. In all models, the AQP4 SNP was the independent variable, FW was the mediator, and the cognitive measure was the dependent variable. On the path SNP → FW, we adjusted for age, sex, and VRFs; on the path SNP → cognition, we adjusted for age, sex, VRFs, education, and APOE ε4 status. A 95% bootstrap confidence interval based on 10,000 bootstrap replicates was used to estimate significance.</p><p>The FDR correction method was used for multiple comparison corrections between glymphatic markers and cognitive scores at the level of three groups to control false positives. Considering the explorative nature of the current study, we reported all statistical results in the paper. The p‐value for statistical significance was set at 0.05, two‐tailed.</p></sec></sec></sec><sec sec-type="results" id="hbm70171-sec-0016"><label>3</label><title>Results</title><sec id="hbm70171-sec-0017"><label>3.1</label><title>Demographics</title><p>This study included 242 non‐demented subjects, among which 95 subjects were A+, and 147 subjects were A−. Subjects in the A+ group had a higher age, more APOE ε4 variations, and higher amyloid PET Centiloids than the A− group. Subjects in the A+ group had significantly worse cognitive performances in MoCA, TMT‐A, and TMT‐B than the A− group. There were no significant differences in glymphatic markers between the A+ group and A− group; please see details in Table <xref rid="hbm70171-tbl-0002" ref-type="table">2</xref>. Among the three imaging markers (Figure <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S10</xref>), BG‐PVS was correlated with FW (<italic toggle="yes">r</italic> = 0.190, <italic toggle="yes">p</italic> = 0.003), and FW was correlated with DTI‐ALPS (<italic toggle="yes">r</italic> = −0.428, <italic toggle="yes">p</italic> &lt; 0.001).</p><table-wrap position="float" id="hbm70171-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Demographic data of participants at baseline.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">All</th><th align="center" valign="bottom" rowspan="1" colspan="1">Group A+</th><th align="center" valign="bottom" rowspan="1" colspan="1">Group A−</th><th align="center" rowspan="2" valign="bottom" colspan="1">
<italic toggle="yes">p</italic>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">(<italic toggle="yes">n</italic> = 242)</th><th align="center" valign="bottom" rowspan="1" colspan="1">(<italic toggle="yes">n</italic> = 95)</th><th align="center" valign="bottom" rowspan="1" colspan="1">(<italic toggle="yes">n</italic> = 147)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age(y)</td><td align="center" valign="top" rowspan="1" colspan="1">76.69 ± 0.49</td><td align="center" valign="top" rowspan="1" colspan="1">78.12 ± 7.18</td><td align="center" valign="top" rowspan="1" colspan="1">75.77 ± 7.85</td><td align="center" valign="top" rowspan="1" colspan="1">0.011</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">111 (45.9)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (50.5)</td><td align="center" valign="top" rowspan="1" colspan="1">63 (42.9)</td><td align="center" valign="top" rowspan="1" colspan="1">0.242</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education (y)</td><td align="center" valign="top" rowspan="1" colspan="1">16.40 ± 0.17</td><td align="center" valign="top" rowspan="1" colspan="1">16.03 ± 2.63</td><td align="center" valign="top" rowspan="1" colspan="1">16.63 ± 2.72</td><td align="center" valign="top" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">117 (48.3)</td><td align="center" valign="top" rowspan="1" colspan="1">47 (49.5)</td><td align="center" valign="top" rowspan="1" colspan="1">70 (47.6)</td><td align="center" valign="top" rowspan="1" colspan="1">0.778</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hyperlipidemia, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">85 (35.1)</td><td align="center" valign="top" rowspan="1" colspan="1">33 (34.7)</td><td align="center" valign="top" rowspan="1" colspan="1">52 (35.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.919</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (5.4)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (5.3)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (5.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.952</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smoking, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (9.5)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (9.5)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (9.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0.990</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APOE ε4 carriers, <italic toggle="yes">N</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">79 (32.6)</td><td align="center" valign="top" rowspan="1" colspan="1">49 (51.6)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (20.4)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amyloid PET Centiloids</td><td align="center" valign="top" rowspan="1" colspan="1">25.52 ± 2.71</td><td align="center" valign="top" rowspan="1" colspan="1">69.32 ± 34.50</td><td align="center" valign="top" rowspan="1" colspan="1">−2.78 ± 10.11</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tau PET SUVR<xref rid="hbm70171-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.22 ± 0.01</td><td align="center" valign="top" rowspan="1" colspan="1">1.26 ± 0.20</td><td align="center" valign="top" rowspan="1" colspan="1">1.19 ± 0.11</td><td align="center" valign="top" rowspan="1" colspan="1">0.186</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Cognitive assessments</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MMSE</td><td align="center" valign="top" rowspan="1" colspan="1">28.53 ± 0.10</td><td align="center" valign="top" rowspan="1" colspan="1">28.33 ± 1.59</td><td align="center" valign="top" rowspan="1" colspan="1">28.66 ± 1.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MoCA</td><td align="center" valign="top" rowspan="1" colspan="1">24.64 ± 0.21</td><td align="center" valign="top" rowspan="1" colspan="1">23.97 ± 3.20</td><td align="center" valign="top" rowspan="1" colspan="1">25.07 ± 3.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CDR global</td><td align="center" valign="top" rowspan="1" colspan="1">0.23 ± 0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.30 ± 0.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.19 ± 0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Logical Memory‐Delayed Recall</td><td align="center" valign="top" rowspan="1" colspan="1">12.90 ± 0.42</td><td align="center" valign="top" rowspan="1" colspan="1">12.03 ± 5.43</td><td align="center" valign="top" rowspan="1" colspan="1">13.49 ± 4.71</td><td align="center" valign="top" rowspan="1" colspan="1">0.178</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TMT‐A</td><td align="center" valign="top" rowspan="1" colspan="1">34.90 ± 0.75</td><td align="center" valign="top" rowspan="1" colspan="1">37.06 ± 11.52</td><td align="center" valign="top" rowspan="1" colspan="1">33.50 ± 11.41</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TMT‐B</td><td align="center" valign="top" rowspan="1" colspan="1">95.39 ± 3.64</td><td align="center" valign="top" rowspan="1" colspan="1">106.15 ± 65.93</td><td align="center" valign="top" rowspan="1" colspan="1">88.39 ± 48.47</td><td align="center" valign="top" rowspan="1" colspan="1">0.039</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">Glymphatic markers</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Basal ganglia PVS</td><td align="center" valign="top" rowspan="1" colspan="1">3 (3–3)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (3–3)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (3–3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.735</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">White matter PVS</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3–4)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3–4)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (3–4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.906</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FW</td><td align="center" valign="top" rowspan="1" colspan="1">0.235 ± 0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.242 ± 0.052</td><td align="center" valign="top" rowspan="1" colspan="1">0.231 ± 0.041</td><td align="center" valign="top" rowspan="1" colspan="1">0.107</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DTI‐ALPS<xref rid="hbm70171-note-0006" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.290 ± 0.014</td><td align="center" valign="top" rowspan="1" colspan="1">1.289 ± 0.212</td><td align="center" valign="top" rowspan="1" colspan="1">1.290 ± 0.224</td><td align="center" valign="top" rowspan="1" colspan="1">0.772</td></tr></tbody></table><table-wrap-foot id="hbm70171-ntgp-0002"><fn id="hbm70171-note-0003"><p>
<italic toggle="yes">Note:</italic> Raw data were presented as mean (± standard deviation [SD]) or number (percentage, %) in tables unless otherwise noted. Data were compared using <italic toggle="yes">t</italic>‐tests or chi‐square tests.</p></fn><fn id="hbm70171-note-0004"><p>Abbreviations: All, the whole group; A+, Aβ positive; A−, Aβ negative; DTI‐ALPS, diffusion tensor image analysis along the perivascular space; FW, free water; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; PVS, perivascular space; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B.</p></fn><fn id="hbm70171-note-0005"><label>
<sup>a</sup>
</label><p>Of the whole group, 133 did not have tau information.</p></fn><fn id="hbm70171-note-0006"><label>
<sup>b</sup>
</label><p>One amyloid‐negative participant without the DTI‐ALPS index due to image registration failure.</p></fn></table-wrap-foot></table-wrap></sec><sec id="hbm70171-sec-0018"><label>3.2</label><title>Associations Between <styled-content style="fixed-case" toggle="no">AQP4 SNPs</styled-content> and the Glymphatic Imaging Markers</title><p>At baseline, none of the AQP4 SNPs was associated with glymphatic markers in the three groups. The detailed results are shown in Tables <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S1</xref>–S3.</p><p>For longitudinal analysis, PVS ratings were not included due to a high PVS burden at baseline. As shown in Table <xref rid="hbm70171-tbl-0002" ref-type="table">2</xref>, both PVS rating scores in the BG and WM regions were high (3 ~ 4) in either the whole group, A+ group, or A− group, which introduced a ceiling effect and limited statistical power. Therefore, we only analyzed the changes in FW and ALPS.</p><p>As shown in Table <xref rid="hbm70171-tbl-0003" ref-type="table">3</xref>, in the whole group, there was no association between AQP4 SNPs and FW changes. In the A+ group, the rs72878794 minor allele carrier status was associated with a slower increase in FW (SNP*time: β = −0.0040, t(46.25) = −2.062, <italic toggle="yes">p</italic> = 0.045, 95% CI = −0.0078 ~ −0.0001). In the A− group, we observed that the rs9951307 minor allele carrier status was associated with a faster increase in FW (SNP*time: β =0.0033, t(81.19) = 2.245, <italic toggle="yes">p</italic> = 0.027, 95% CI = 0.0004 ~ 0.0062). No significant associations had been found between the AQP4 SNPs and DTI‐ALPs changes.</p><table-wrap position="float" id="hbm70171-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Associations between AQP4 SNPs and longitudinal glymphatic imaging markers change.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="3" valign="bottom" colspan="1">Independent variables</th><th align="center" colspan="4" valign="bottom" rowspan="1">All group</th><th align="center" colspan="4" valign="bottom" rowspan="1">A+ group</th><th align="center" colspan="4" valign="bottom" rowspan="1">A− group</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" colspan="2" valign="bottom" rowspan="1">FW</th><th align="center" colspan="2" valign="bottom" rowspan="1">DTI‐ALPS</th><th align="center" colspan="2" valign="bottom" rowspan="1">FW</th><th align="center" colspan="2" valign="bottom" rowspan="1">DTI‐ALPS</th><th align="center" colspan="2" valign="bottom" rowspan="1">FW</th><th align="center" colspan="2" valign="bottom" rowspan="1">DTI‐ALPS</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">0.0031</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0054</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0062</td><td align="center" valign="top" rowspan="1" colspan="1">0.053</td><td align="center" valign="top" rowspan="1" colspan="1">0.0030</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0049</td><td align="center" valign="top" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0023</td><td align="center" valign="top" rowspan="1" colspan="1">0.698</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0797</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">0.0068</td><td align="center" valign="top" rowspan="1" colspan="1">0.538</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0704</td><td align="center" valign="top" rowspan="1" colspan="1">0.091</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0066</td><td align="center" valign="top" rowspan="1" colspan="1">0.341</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0815</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VRFs</td><td align="center" valign="top" rowspan="1" colspan="1">0.0036</td><td align="center" valign="top" rowspan="1" colspan="1">0.284</td><td align="center" valign="top" rowspan="1" colspan="1">0.0131</td><td align="center" valign="top" rowspan="1" colspan="1">0.381</td><td align="center" valign="top" rowspan="1" colspan="1">0.0055</td><td align="center" valign="top" rowspan="1" colspan="1">0.377</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0308</td><td align="center" valign="top" rowspan="1" colspan="1">0.194</td><td align="center" valign="top" rowspan="1" colspan="1">0.0031</td><td align="center" valign="top" rowspan="1" colspan="1">0.424</td><td align="center" valign="top" rowspan="1" colspan="1">0.0389</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WM MD</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0660</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0737</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">—</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0627</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time</td><td align="center" valign="top" rowspan="1" colspan="1">0.0036</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0135</td><td align="center" valign="top" rowspan="1" colspan="1">0.068</td><td align="center" valign="top" rowspan="1" colspan="1">0.0055</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0366</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">0.0029</td><td align="center" valign="top" rowspan="1" colspan="1">0.063</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0047</td><td align="center" valign="top" rowspan="1" colspan="1">0.603</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs9951307</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0069</td><td align="center" valign="top" rowspan="1" colspan="1">0.242</td><td align="center" valign="top" rowspan="1" colspan="1">0.0049</td><td align="center" valign="top" rowspan="1" colspan="1">0.869</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0087</td><td align="center" valign="top" rowspan="1" colspan="1">0.423</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0384</td><td align="center" valign="top" rowspan="1" colspan="1">0.424</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0053</td><td align="center" valign="top" rowspan="1" colspan="1">0.449</td><td align="center" valign="top" rowspan="1" colspan="1">0.0065</td><td align="center" valign="top" rowspan="1" colspan="1">0.865</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763043</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0106</td><td align="center" valign="top" rowspan="1" colspan="1">0.076</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0233</td><td align="center" valign="top" rowspan="1" colspan="1">0.432</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0245</td><td align="center" valign="top" rowspan="1" colspan="1">0.030</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0412</td><td align="center" valign="top" rowspan="1" colspan="1">0.412</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0033</td><td align="center" valign="top" rowspan="1" colspan="1">0.639</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0123</td><td align="center" valign="top" rowspan="1" colspan="1">0.744</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763040</td><td align="center" valign="top" rowspan="1" colspan="1">0.0032</td><td align="center" valign="top" rowspan="1" colspan="1">0.602</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0129</td><td align="center" valign="top" rowspan="1" colspan="1">0.675</td><td align="center" valign="top" rowspan="1" colspan="1">0.0073</td><td align="center" valign="top" rowspan="1" colspan="1">0.523</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0319</td><td align="center" valign="top" rowspan="1" colspan="1">0.527</td><td align="center" valign="top" rowspan="1" colspan="1">0.0023</td><td align="center" valign="top" rowspan="1" colspan="1">0.761</td><td align="center" valign="top" rowspan="1" colspan="1">0.0043</td><td align="center" valign="top" rowspan="1" colspan="1">0.916</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3875089</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0023</td><td align="center" valign="top" rowspan="1" colspan="1">0.733</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0013</td><td align="center" valign="top" rowspan="1" colspan="1">0.970</td><td align="center" valign="top" rowspan="1" colspan="1">0.0067</td><td align="center" valign="top" rowspan="1" colspan="1">0.597</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0068</td><td align="center" valign="top" rowspan="1" colspan="1">0.903</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0055</td><td align="center" valign="top" rowspan="1" colspan="1">0.496</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0183</td><td align="center" valign="top" rowspan="1" colspan="1">0.671</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs151244</td><td align="center" valign="top" rowspan="1" colspan="1">0.0062</td><td align="center" valign="top" rowspan="1" colspan="1">0.298</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0340</td><td align="center" valign="top" rowspan="1" colspan="1">0.251</td><td align="center" valign="top" rowspan="1" colspan="1">0.0017</td><td align="center" valign="top" rowspan="1" colspan="1">0.878</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0160</td><td align="center" valign="top" rowspan="1" colspan="1">0.739</td><td align="center" valign="top" rowspan="1" colspan="1">0.0061</td><td align="center" valign="top" rowspan="1" colspan="1">0.405</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0543</td><td align="center" valign="top" rowspan="1" colspan="1">0.170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs72878794</td><td align="center" valign="top" rowspan="1" colspan="1">0.0086</td><td align="center" valign="top" rowspan="1" colspan="1">0.259</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0229</td><td align="center" valign="top" rowspan="1" colspan="1">0.548</td><td align="center" valign="top" rowspan="1" colspan="1">0.0088</td><td align="center" valign="top" rowspan="1" colspan="1">0.548</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0800</td><td align="center" valign="top" rowspan="1" colspan="1">0.213</td><td align="center" valign="top" rowspan="1" colspan="1">0.0051</td><td align="center" valign="top" rowspan="1" colspan="1">0.567</td><td align="center" valign="top" rowspan="1" colspan="1">0.0079</td><td align="center" valign="top" rowspan="1" colspan="1">0.868</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs9951307 × time</td><td align="center" valign="top" rowspan="1" colspan="1">0.0018</td><td align="center" valign="top" rowspan="1" colspan="1">0.110</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0071</td><td align="center" valign="top" rowspan="1" colspan="1">0.286</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0016</td><td align="center" valign="top" rowspan="1" colspan="1">0.305</td><td align="center" valign="top" rowspan="1" colspan="1">0.0093</td><td align="center" valign="top" rowspan="1" colspan="1">0.393</td><td align="center" valign="top" rowspan="1" colspan="1">0.0033</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.027</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0123</td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763043 × time</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.559</td><td align="center" valign="top" rowspan="1" colspan="1">0.0036</td><td align="center" valign="top" rowspan="1" colspan="1">0.580</td><td align="center" valign="top" rowspan="1" colspan="1">0.0022</td><td align="center" valign="top" rowspan="1" colspan="1">0.198</td><td align="center" valign="top" rowspan="1" colspan="1">0.0055</td><td align="center" valign="top" rowspan="1" colspan="1">0.645</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0017</td><td align="center" valign="top" rowspan="1" colspan="1">0.257</td><td align="center" valign="top" rowspan="1" colspan="1">0.0013</td><td align="center" valign="top" rowspan="1" colspan="1">0.872</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3763040 × time</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0020</td><td align="center" valign="top" rowspan="1" colspan="1">0.093</td><td align="center" valign="top" rowspan="1" colspan="1">0.0084</td><td align="center" valign="top" rowspan="1" colspan="1">0.226</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0008</td><td align="center" valign="top" rowspan="1" colspan="1">0.630</td><td align="center" valign="top" rowspan="1" colspan="1">0.0191</td><td align="center" valign="top" rowspan="1" colspan="1">0.096</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0027</td><td align="center" valign="top" rowspan="1" colspan="1">0.088</td><td align="center" valign="top" rowspan="1" colspan="1">0.0057</td><td align="center" valign="top" rowspan="1" colspan="1">0.522</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs3875089 × time</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td><td align="center" valign="top" rowspan="1" colspan="1">0.779</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0052</td><td align="center" valign="top" rowspan="1" colspan="1">0.486</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0017</td><td align="center" valign="top" rowspan="1" colspan="1">0.360</td><td align="center" valign="top" rowspan="1" colspan="1">0.0039</td><td align="center" valign="top" rowspan="1" colspan="1">0.762</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.474</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0078</td><td align="center" valign="top" rowspan="1" colspan="1">0.394</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs151244 × time</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0016</td><td align="center" valign="top" rowspan="1" colspan="1">0.147</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0031</td><td align="center" valign="top" rowspan="1" colspan="1">0.642</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0014</td><td align="center" valign="top" rowspan="1" colspan="1">0.382</td><td align="center" valign="top" rowspan="1" colspan="1">0.0010</td><td align="center" valign="top" rowspan="1" colspan="1">0.933</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0014</td><td align="center" valign="top" rowspan="1" colspan="1">0.374</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0057</td><td align="center" valign="top" rowspan="1" colspan="1">0.508</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs72878794 × time</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.586</td><td align="center" valign="top" rowspan="1" colspan="1">0.0102</td><td align="center" valign="top" rowspan="1" colspan="1">0.198</td><td align="center" valign="top" rowspan="1" colspan="1">−0.0040</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.045</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.0097</td><td align="center" valign="top" rowspan="1" colspan="1">0.464</td><td align="center" valign="top" rowspan="1" colspan="1">0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">0.973</td><td align="center" valign="top" rowspan="1" colspan="1">0.0106</td><td align="center" valign="top" rowspan="1" colspan="1">0.275</td></tr></tbody></table><table-wrap-foot id="hbm70171-ntgp-0003"><fn id="hbm70171-note-0007"><p>
<italic toggle="yes">Note:</italic> Reported are estimates and p‐values from linear mixed models with random intercepts and random slopes. The fixed effect of SNP*time was interpreted as the effect on longitudinal glymphatic change.</p></fn><fn id="hbm70171-note-0008"><p>Abbreviations: All, the whole group; A−, Aβ negative; A+, Aβ positive; DTI‐ALPS, diffusion tensor image analysis along the perivascular space; FW, free water; MD, mean diffusivity; SNP, single‐nucleotide polymorphism; VRFs, vascular risk factor score; WM, white matter.</p></fn></table-wrap-foot></table-wrap></sec><sec id="hbm70171-sec-0019"><label>3.3</label><title>Associations Between <styled-content style="fixed-case" toggle="no">FW</styled-content> and Clinical Variables</title><p>In the cross‐sectional analysis of the whole group (Table <xref rid="hbm70171-tbl-0004" ref-type="table">4</xref> and Figure <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S7</xref>), a higher FW was associated with a lower MMSE score (β‐std = −0.162, t(232) = −2.207, <italic toggle="yes">p</italic> = 0.028, 95% CI = −0.307 ~ −0.017), a lower MoCA score (β‐std = −0.190, t(235) = −2.782, <italic toggle="yes">p</italic> = 0.006, 95% CI = −0.325 ~ −0.056), a higher CDR score (β‐std = 0.226, t(233) = 3.150, <italic toggle="yes">p</italic> = 0.002, 95% CI = 0.084 ~ 0.367), a lower Logical Memory‐Delayed Recall score (β‐std = −0.256, t(140) = −2.966, <italic toggle="yes">p</italic> = 0.004, 95% CI = −0.427 ~ −0.085), and a longer TMT‐B time (β‐std = 0.223, t(234) = 3.282, <italic toggle="yes">p</italic> = 0.001, 95% CI = 0.089 ~ 0.357). For the A+ group (Table <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S5</xref> and Figure <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S8</xref>), more details can be found in the <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>. For the A− group (Table <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S6</xref> and Figure <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S9</xref>), we observed associations between a higher FW and a lower MoCA score (β‐std = −0.197, t(140) = −2.202, <italic toggle="yes">p</italic> = 0.029, 95% CI = −0.373 ~ −0.020), a higher CDR score (β‐std = 0.313, t(138) = 3.427, p = 0.001, 95% CI = 0.133 ~ 0.494), a lower Logical Memory‐Delayed Recall score (β‐std = −0.039, t(81) = −2.716, <italic toggle="yes">p</italic> = 0.008, 95% CI = −0.536 ~ −0.083), and a longer TMT‐B time (β‐std = 0.255, t(139) = 2.974, <italic toggle="yes">p</italic> = 0.003, 95% CI = 0.085 ~ 0.424).</p><table-wrap position="float" id="hbm70171-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Cross‐sectional associations between glymphatic imaging markers and cognitive measures in the whole group.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="3" valign="bottom" colspan="1">Independent variables</th><th align="center" colspan="12" valign="bottom" rowspan="1">Cognitive assessment</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" colspan="2" valign="bottom" rowspan="1">MMSE</th><th align="center" colspan="2" valign="bottom" rowspan="1">MoCA</th><th align="center" colspan="2" valign="bottom" rowspan="1">CDR global</th><th align="center" colspan="2" valign="bottom" rowspan="1">Logistic delayed</th><th align="center" colspan="2" valign="bottom" rowspan="1">TMT‐A</th><th align="center" colspan="2" valign="bottom" rowspan="1">TMT‐B</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β‐std</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">−0.008</td><td align="center" valign="top" rowspan="1" colspan="1">0.920</td><td align="center" valign="top" rowspan="1" colspan="1">−0.087</td><td align="center" valign="top" rowspan="1" colspan="1">0.215</td><td align="center" valign="top" rowspan="1" colspan="1">−0.141</td><td align="center" valign="top" rowspan="1" colspan="1">0.056</td><td align="center" valign="top" rowspan="1" colspan="1">0.062</td><td align="center" valign="top" rowspan="1" colspan="1">0.515</td><td align="center" valign="top" rowspan="1" colspan="1">0.217</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.148</td><td align="center" valign="top" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1">0.011</td><td align="center" valign="top" rowspan="1" colspan="1">0.876</td><td align="center" valign="top" rowspan="1" colspan="1">0.162</td><td align="center" valign="top" rowspan="1" colspan="1">0.010</td><td align="center" valign="top" rowspan="1" colspan="1">−0.175</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">0.028</td><td align="center" valign="top" rowspan="1" colspan="1">0.734</td><td align="center" valign="top" rowspan="1" colspan="1">−0.090</td><td align="center" valign="top" rowspan="1" colspan="1">0.165</td><td align="center" valign="top" rowspan="1" colspan="1">−0.048</td><td align="center" valign="top" rowspan="1" colspan="1">0.446</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VRFs</td><td align="center" valign="top" rowspan="1" colspan="1">−0.003</td><td align="center" valign="top" rowspan="1" colspan="1">0.967</td><td align="center" valign="top" rowspan="1" colspan="1">−0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.988</td><td align="center" valign="top" rowspan="1" colspan="1">−0.084</td><td align="center" valign="top" rowspan="1" colspan="1">0.187</td><td align="center" valign="top" rowspan="1" colspan="1">0.181</td><td align="center" valign="top" rowspan="1" colspan="1">0.016</td><td align="center" valign="top" rowspan="1" colspan="1">0.066</td><td align="center" valign="top" rowspan="1" colspan="1">0.295</td><td align="center" valign="top" rowspan="1" colspan="1">0.058</td><td align="center" valign="top" rowspan="1" colspan="1">0.334</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education</td><td align="center" valign="top" rowspan="1" colspan="1">0.116</td><td align="center" valign="top" rowspan="1" colspan="1">0.089</td><td align="center" valign="top" rowspan="1" colspan="1">0.334</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.225</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.288</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.147</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td><td align="center" valign="top" rowspan="1" colspan="1">−0.240</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APOE</td><td align="center" valign="top" rowspan="1" colspan="1">−0.157</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">−0.123</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td><td align="center" valign="top" rowspan="1" colspan="1">0.121</td><td align="center" valign="top" rowspan="1" colspan="1">0.057</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">0.835</td><td align="center" valign="top" rowspan="1" colspan="1">0.153</td><td align="center" valign="top" rowspan="1" colspan="1">0.016</td><td align="center" valign="top" rowspan="1" colspan="1">0.189</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FW</td><td align="center" valign="top" rowspan="1" colspan="1">−0.162</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.028*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">−0.190</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.006*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.226</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.002*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">−0.256</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.004*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.117</td><td align="center" valign="top" rowspan="1" colspan="1">0.100</td><td align="center" valign="top" rowspan="1" colspan="1">0.223</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.001*</bold>
</td></tr></tbody></table><table-wrap-foot id="hbm70171-ntgp-0004"><fn id="hbm70171-note-0009"><p>
<italic toggle="yes">Note:</italic> Bold and * meant corrected by FDR, β‐std, and standardized betas.</p></fn><fn id="hbm70171-note-0010"><p>Abbreviations: FW, free water; Logical delayed, Logical Memory‐Delayed Recall; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B; VRFs, vascular risk factor score.</p></fn></table-wrap-foot></table-wrap><p>For longitudinal analysis in the whole group (Table <xref rid="hbm70171-tbl-0005" ref-type="table">5</xref>), a higher baseline FW was associated with a faster decline in MMSE score (FW * time: <italic toggle="yes">β</italic> = −2.952, t(119.06) = −3.425, <italic toggle="yes">p</italic> = 0.001, 95% CI = −4.679 ~ −1.239), a faster increase in CDR score (FW * time: <italic toggle="yes">β</italic> = 0.550, t(97.28) = 5.799, <italic toggle="yes">p</italic> &lt; 0.001, 95% CI = 0.361 ~ 0.737), and a faster increase in TMT‐A completion time (FW * time: <italic toggle="yes">β</italic> = 20.491, t(245.26) = 4.543, <italic toggle="yes">p</italic> &lt; 0.001, 95% CI = 11.564 ~ 29.354). In the A+ group (Table <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S7</xref>), a higher baseline FW was associated with a faster increase in CDR score (FW * time: β = 0.675, t(36.68) = 4.087, <italic toggle="yes">p</italic> &lt; 0.001, 95% CI = 0.330 ~ 1.006), a slower decline in Logical Memory‐Delayed Recall score (FW * time: <italic toggle="yes">β</italic> = 7.152, t(32.11) = 2.451, <italic toggle="yes">p</italic> = 0.020, 95% CI = 1.256 ~ 13.066), and a faster increase in TMT‐A completion time (FW * time: β = 28.398, t(41.90) = 2.560, <italic toggle="yes">p</italic> = 0.014, 95% CI = 6.255 ~ 50.780). In the A− group (Table <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S8</xref>), we also observed that higher baseline FW was associated with a faster increase in CDR score (FW * time: <italic toggle="yes">β</italic> = 0.447, t(60.11) = 3.869, <italic toggle="yes">p</italic> &lt; 0.001, 95% CI = 0.218 ~ 0.679) and a faster increase in TMT‐A completion time (FW * time: <italic toggle="yes">β</italic> = 18.070, t(50.06) = 3.369, p = 0.001, 95% CI = 6.962 ~ 28.750).</p><table-wrap position="float" id="hbm70171-tbl-0005" content-type="TABLE" orientation="portrait"><label>TABLE 5</label><caption><p>Associations between baseline glymphatic imaging markers and longitudinal changes in cognitive measures in the whole group.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="3" valign="bottom" colspan="1">Independent variables</th><th align="center" colspan="12" valign="bottom" rowspan="1">Cognitive assessment</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" colspan="2" valign="bottom" rowspan="1">MMSE</th><th align="center" colspan="2" valign="bottom" rowspan="1">MoCA</th><th align="center" colspan="2" valign="bottom" rowspan="1">CDR global</th><th align="center" colspan="2" valign="bottom" rowspan="1">Logistic delayed</th><th align="center" colspan="2" valign="bottom" rowspan="1">TMT‐A</th><th align="center" colspan="2" valign="bottom" rowspan="1">TMT‐B</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">β</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.942</td><td align="center" valign="top" rowspan="1" colspan="1">−0.053</td><td align="center" valign="top" rowspan="1" colspan="1">0.081</td><td align="center" valign="top" rowspan="1" colspan="1">−0.004</td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td><td align="center" valign="top" rowspan="1" colspan="1">0.068</td><td align="center" valign="top" rowspan="1" colspan="1">0.210</td><td align="center" valign="top" rowspan="1" colspan="1">0.313</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">1.713</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1">−0.057</td><td align="center" valign="top" rowspan="1" colspan="1">0.776</td><td align="center" valign="top" rowspan="1" colspan="1">−0.764</td><td align="center" valign="top" rowspan="1" colspan="1">0.059</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td><td align="center" valign="top" rowspan="1" colspan="1">0.189</td><td align="center" valign="top" rowspan="1" colspan="1">−1.561</td><td align="center" valign="top" rowspan="1" colspan="1">0.029</td><td align="center" valign="top" rowspan="1" colspan="1">2.256</td><td align="center" valign="top" rowspan="1" colspan="1">0.143</td><td align="center" valign="top" rowspan="1" colspan="1">8.801</td><td align="center" valign="top" rowspan="1" colspan="1">0.203</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education</td><td align="center" valign="top" rowspan="1" colspan="1">0.101</td><td align="center" valign="top" rowspan="1" colspan="1">0.006</td><td align="center" valign="top" rowspan="1" colspan="1">0.399</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.014</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td><td align="center" valign="top" rowspan="1" colspan="1">0.493</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.847</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">−6.544</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APOE</td><td align="center" valign="top" rowspan="1" colspan="1">−0.633</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">−0.543</td><td align="center" valign="top" rowspan="1" colspan="1">0.188</td><td align="center" valign="top" rowspan="1" colspan="1">0.078</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td><td align="center" valign="top" rowspan="1" colspan="1">−1.498</td><td align="center" valign="top" rowspan="1" colspan="1">0.044</td><td align="center" valign="top" rowspan="1" colspan="1">3.625</td><td align="center" valign="top" rowspan="1" colspan="1">0.023</td><td align="center" valign="top" rowspan="1" colspan="1">18.064</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VRFs</td><td align="center" valign="top" rowspan="1" colspan="1">0.026</td><td align="center" valign="top" rowspan="1" colspan="1">0.815</td><td align="center" valign="top" rowspan="1" colspan="1">−0.025</td><td align="center" valign="top" rowspan="1" colspan="1">0.909</td><td align="center" valign="top" rowspan="1" colspan="1">−0.007</td><td align="center" valign="top" rowspan="1" colspan="1">0.728</td><td align="center" valign="top" rowspan="1" colspan="1">0.657</td><td align="center" valign="top" rowspan="1" colspan="1">0.095</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">0.879</td><td align="center" valign="top" rowspan="1" colspan="1">−0.772</td><td align="center" valign="top" rowspan="1" colspan="1">0.842</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FW</td><td align="center" valign="top" rowspan="1" colspan="1">−3.864</td><td align="center" valign="top" rowspan="1" colspan="1">0.117</td><td align="center" valign="top" rowspan="1" colspan="1">−5.756</td><td align="center" valign="top" rowspan="1" colspan="1">0.258</td><td align="center" valign="top" rowspan="1" colspan="1">0.655</td><td align="center" valign="top" rowspan="1" colspan="1">0.142</td><td align="center" valign="top" rowspan="1" colspan="1">−29.748</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">27.087</td><td align="center" valign="top" rowspan="1" colspan="1">0.154</td><td align="center" valign="top" rowspan="1" colspan="1">217.417</td><td align="center" valign="top" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time</td><td align="center" valign="top" rowspan="1" colspan="1">0.572</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">0.326</td><td align="center" valign="top" rowspan="1" colspan="1">0.293</td><td align="center" valign="top" rowspan="1" colspan="1">−0.110</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−0.055</td><td align="center" valign="top" rowspan="1" colspan="1">0.893</td><td align="center" valign="top" rowspan="1" colspan="1">−4.268</td><td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td><td align="center" valign="top" rowspan="1" colspan="1">−1.768</td><td align="center" valign="top" rowspan="1" colspan="1">0.643</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FW×time</td><td align="center" valign="top" rowspan="1" colspan="1">−2.952</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.001*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">−2.384</td><td align="center" valign="top" rowspan="1" colspan="1">0.073</td><td align="center" valign="top" rowspan="1" colspan="1">0.550</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&lt; 0.001*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td><td align="center" valign="top" rowspan="1" colspan="1">0.980</td><td align="center" valign="top" rowspan="1" colspan="1">20.491</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&lt; 0.001*</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">11.080</td><td align="center" valign="top" rowspan="1" colspan="1">0.500</td></tr></tbody></table><table-wrap-foot id="hbm70171-ntgp-0005"><fn id="hbm70171-note-0011"><p>
<italic toggle="yes">Note:</italic> Reported are estimates and <italic toggle="yes">p</italic>‐values from linear mixed models with random intercepts and random slopes. The fixed effect of glymphatic marker*time was interpreted as the effect on longitudinal glymphatic change. Bold and * meant corrected by FDR.</p></fn><fn id="hbm70171-note-0012"><p>Abbreviations: FW, free water; Logical Delayed, Logical Memory‐Delayed Recall; MMSE, Mini‐Mental State Exam; MoCA, Montreal Cognitive Assessment; TMT‐A, Trail Making Test‐A; TMT‐B, Trail Making Test‐B; VRFs, vascular risk factor score.</p></fn></table-wrap-foot></table-wrap><p>In both cross‐sectional and longitudinal analyses, we did not observe any associations between FW and amyloid accumulation. The results are shown in Table <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S4</xref>.</p></sec><sec id="hbm70171-sec-0020"><label>3.4</label><title>Mediation Analyses Between <styled-content style="fixed-case" toggle="no">AQP4 SNPs</styled-content>, <styled-content style="fixed-case" toggle="no">FW</styled-content>, and Cognitive Performance</title><p>In all models, we had not observed FW's mediation role between AQP4 SNPs and cognition. Specifically, in the Aβ positive group, the effect of rs72878794 on CDR via FW was not significant (β = −0.0047, <italic toggle="yes">p</italic> = 0.08); the effect of rs72878794 on Logical Memory‐Delayed Recall via FW was not significant (β = 0.0246, <italic toggle="yes">p</italic> = 0.45); the effect of rs72878794 on TMT‐A via FW was not significant (β = −0.1710, <italic toggle="yes">p</italic> = 0.34). In the Aβ negative group, the effect of rs9951307 on the CDR ratio via FW was not significant (β = −0.0005, <italic toggle="yes">p</italic> = 0.56); the effect of rs9951307 on TMT‐A ratio via FW was not significant (β = 0.0557, p = 0.08). Detailed results are shown in Figures <xref rid="hbm70171-supitem-0001" ref-type="supplementary-material">S2–S6</xref>.</p></sec></sec><sec sec-type="discussion" id="hbm70171-sec-0021"><label>4</label><title>Discussion</title><p>In this study, we explored the effects of AQP4 SNPs on glymphatic markers and AD progression in non‐demented participants. Results showed that the AQP4 SNP rs72878794 minor allele carrier status was associated with a slower increase in FW in the Aβ positive group, and the AQP4 SNP rs9951307 minor allele carrier status was associated with a faster increase in FW in the Aβ negative group. FW was associated with global cognition, memory, and executive function in both cross‐sectional and longitudinal analyses. These results may provide insights for understanding the influence of AQP4 SNPs on the glymphatic system and AD progression.</p><p>This is the first in vivo study revealing the effect of AQP4 SNPs on WM FW. FW is a diffusion imaging marker that measures the fraction of water content with unrestricted and isotropic diffusion. An elevated FW may reflect an increase in ISF (Duering et al. <xref rid="hbm70171-bib-0006" ref-type="bibr">2018</xref>; Zhang, Huang, et al. <xref rid="hbm70171-bib-0045" ref-type="bibr">2021</xref>; Zhang, Zhou, et al. <xref rid="hbm70171-bib-0046" ref-type="bibr">2021</xref>). Because AQP4 proteins are crucial for the CSF –ISF exchange, their structural and functional variations may alter the water permeability and change the glymphatic flow. A previous study found that mice with genetic deletion of AQP4 (AQP4 KO) had larger interstitial spaces and higher brain water content, despite a similar CSF production rate and vascular density (Gomolka et al. <xref rid="hbm70171-bib-0009" ref-type="bibr">2023</xref>). Furthermore, the increased interstitial space was associated with a higher water diffusivity. These results suggested that AQP4 KO could result in a reduction in glymphatic flow and lead to stagnation of fluid in the interstitial space. Although this evidence is useful for understanding the modulation of glymphatic flow and for developing potential treatment methods, no study has investigated the effect of AQP4 SNPs on glymphatic function in humans, which could be mild compared to the extreme gene knock‐out approaches.</p><p>The AQP4 is encoded by a 3 kb gene located on chromosome 18. Depending on the selection of two transcription starting sites, it can be translated into AQP4‐M1 or AQP4‐M23 isoforms, which differ in structural characteristics and their ability to form orthogonal arrays of particles, thereby affecting the water permeability of AQP4 (Nagelhus and Ottersen <xref rid="hbm70171-bib-0024" ref-type="bibr">2013</xref>; Smith et al. <xref rid="hbm70171-bib-0035" ref-type="bibr">2014</xref>). The rs72878794 is located in the promoter region upstream of exon 0 of the AQP4 gene (Figure <xref rid="hbm70171-fig-0002" ref-type="fig">2</xref>). Its polymorphism may lead to differential expression of isoforms and subsequent downstream events (Zhang, Huang, et al. <xref rid="hbm70171-bib-0045" ref-type="bibr">2021</xref>; Zhang, Zhou, et al. <xref rid="hbm70171-bib-0046" ref-type="bibr">2021</xref>; Hook‐Barnard and Hinton <xref rid="hbm70171-bib-0012" ref-type="bibr">2007</xref>). In the cortex of AD patients, a decrease in the M1‐to‐M23 isoform ratio was associated with changes in the localization of AQP4 (Zeppenfeld et al. <xref rid="hbm70171-bib-0044" ref-type="bibr">2017</xref>), but how they exactly influence AD pathology accumulation awaits further investigation. Chandra et al. (Chandra et al. <xref rid="hbm70171-bib-0004" ref-type="bibr">2021</xref>) found that AQP4 SNP rs72878794 minor allele carrier status was associated with decreased Florbetapir SUVRs, and they inferred that an altered glymphatic function might mediate the association. Here, we found that the AQP4 SNP rs72878794 minor allele carrier status was associated with a slower longitudinal increase in FW. Consistent with Chandra's study, this result implies a protective role of rs72878794 minor allele carrier status.</p><p>The rs9951307 is located at the C‐terminal end of AQP4, approximately 15 kb downstream of the AQP4 UGA canonical stop codon (Rainey‐Smith et al. <xref rid="hbm70171-bib-0031" ref-type="bibr">2018</xref>), in a region that lacks known transcription factor‐binding sites. Burfeind's study (Burfeind et al. <xref rid="hbm70171-bib-0003" ref-type="bibr">2017</xref>), using a longitudinal aging cohort, found that rs9951307 minor allele carrier status was associated with a slower cognitive decline in subjects diagnosed with AD. However, we found that the rs9951307 minor allele carrier status was associated with a faster increase in FW, which is detrimental, in the Aβ‐negative group. The discrepancy may result from various reasons. Burfeind's study included subjects diagnosed with AD. Because clinically diagnosed AD was already in a late stage, complex degenerative pathologies might be involved, obscuring the effect of AQP4 SNPs. Studying non‐demented populations may reduce these confounding factors and provide an understanding of early pathological mechanisms. Our finding is consistent with a study showing that rs9951307 minor allele status was associated with severe brain edema (Kleffner et al. <xref rid="hbm70171-bib-0020" ref-type="bibr">2008</xref>) in stroke patients. Since rs9951307 does not change the amino acid sequence, it is unlikely to affect the function of AQP4. Its association with clinical features might be due to other gene variations that are in linkage disequilibrium with rs9951307, but further experiments are needed to gain insights about the detailed mechanisms.</p><p>FW has been found sensitive to cognitive impairments. Maillard (Maillard et al. <xref rid="hbm70171-bib-0022" ref-type="bibr">2017</xref>) et al. found that higher baseline FW was associated with lower global cognition, memory, and executive function. Furthermore, longitudinal changes in FW were also associated with the decline of cognitive function. Several other studies also reported the relationships in community cohorts, patients with cerebral vascular diseases (Huang et al. <xref rid="hbm70171-bib-0014" ref-type="bibr">2022</xref>), AD continuum (Kamagata et al. <xref rid="hbm70171-bib-0018" ref-type="bibr">2022</xref>; Zhu et al. <xref rid="hbm70171-bib-0048" ref-type="bibr">2022</xref>), etc. In this study, we confirmed their associations in both cross‐sectional and longitudinal analyses. However, there was no significant correlation between FW and amyloid accumulation, and we had not investigated the association between FW and tau due to a small sample size. It should be noted that ISF stagnation may influence the clearance of a wide range of metabolic wastes and poisonous proteins, and it may cause brain degeneration through other pathological mechanisms rather than amyloid accumulation. Further studies are needed to clarify the detailed mechanism.</p><p>We did not observe any associations between SNPs and PVS or ALPS. Although the three imaging markers are all related to the glymphatic system, they reflect different structural or functional properties, as discussed above. These properties are influenced by distinct pathological processes, such as arterial stiffness or venous collagenosis. As a result, the three markers may not exhibit simultaneous changes under a specific disease condition but instead display varied alteration patterns across different neurological diseases.</p><p>This study is subject to several limitations. First, we included only SNPs that are associated with AD, and thus, we cannot dismiss the potential impact of previously reported SNPs unrelated to AD on our results. Second, the sample size was relatively small for uncovering associations between genetic variations and clinical or imaging features due to the requirements for genetic data and multi‐sequence imaging data. This limitation may explain the lack of significant findings regarding PVS and DTI‐ALPS. Similarly, although AQP4 SNPs were associated with FW, and FW was associated with cognitive scores, we did not observe a mediation effect, possibly due to a small effect size. While ADNI is already the largest multi‐center project focused on AD, a substantial portion of data has not yet been released. Future studies with larger sample sizes are necessary to validate our findings. Third, the involvement of multiple research centers may contribute to variability in diffusion metrics. However, as the acquisition protocol of ADNI has been harmonized by a specialized imaging core and we have conducted multi‐center harmonization, these differences should have been minimized. Lastly, although we used the three most widely used markers to represent glymphatic‐related changes, the pathophysiological underpinnings of these markers are still undergoing validation. Caution should be exercised when interpreting the results.</p></sec><sec sec-type="conclusions" id="hbm70171-sec-0022"><label>5</label><title>Conclusion</title><p>AQP4 SNPs are associated with FW accumulation, which is further associated with longitudinal cognitive decline.</p></sec><sec id="hbm70171-sec-0023"><label>6</label><title>
<styled-content style="fixed-case" toggle="no">ADNI</styled-content> Consortia Information</title><p>Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf" ext-link-type="uri">http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf</ext-link>.</p></sec><sec id="hbm70171-sec-0024"><title>Author Contributions</title><p>Lingyun Liu and Qingze Zeng: conceptualization; methodology; writing – review and editing; data curation. Xiao Luo: conceptualization; methodology; data curation. Hui Hong: methodology; writing – review and editing. Yi Fang: conceptualization; methodology. Linyun Xie, Yao Zhang, Miao Lin, Shuyue Wang, Kaicheng Li, and Xiaocao Liu: data curation. Ruiting Zhang and Yanxing Chen: writing – review. Yunjun Yang and Peiyu Huang: conceptualization; methodology; writing – review and editing.</p></sec><sec id="hbm70171-sec-0027"><title>Ethics Statement</title><p>All procedures performed in studies involving human participants were under the ethical standards of the Institutional and National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants and authorized representatives, and the study partners before any protocol‐specific procedures were carried out in the ADNI study. More details can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.adni-info.org" ext-link-type="uri">http://www.adni‐info.org</ext-link>.</p></sec><sec sec-type="conclusions" id="hbm70171-sec-0026"><title>Consent</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="hbm70171-sec-0030"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="hbm70171-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Data S1.
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-46-e70171-s001.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="hbm70171-sec-0025"><title>Acknowledgements</title><p>The data collection and sharing for this project were funded by the ADNI (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense Award No. W81XWH‐12‐2‐0012). ADNI was funded by the NIA and the NIBIB and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio Clinica Inc.; Biogen; Bristol‐Myers Squibb Company; Cere Spir Inc.; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; Euro Immun; F. Hoffmann‐La Roche Ltd. and its affiliated company Genentech Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &amp; Development LLC; Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC; Lumosity; Lundbeck; Merck &amp; Co. Inc.; MesoScale Diagnostics LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.fnih.org" ext-link-type="uri">www.fnih.org</ext-link>). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the AD Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuroimaging at the University of Southern California.</p></ack><sec sec-type="data-availability" id="hbm70171-sec-0029"><title>Data Availability Statement</title><p>The data that support the findings of this study are openly available in ADNI at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ida.loni.usc.edu/home/projectPage.jsp?project=ADNI" ext-link-type="uri" specific-use="software is-supplemented-by">https://ida.loni.usc.edu/home/projectPage.jsp?project=ADNI</ext-link>.</p></sec><ref-list content-type="cited-references" id="hbm70171-bibl-0001"><title>References</title><ref id="hbm70171-bib-0001"><mixed-citation publication-type="journal" id="hbm70171-cit-0001"><string-name name-style="western"><surname>Benveniste</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Lee</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Ding</surname></string-name>, et al. <year>2017</year>. “<article-title>Anesthesia With Dexmedetomidine and Low‐Dose Isoflurane Increases Solute Transport via the Glymphatic Pathway in Rat Brain When Compared With High‐Dose Isoflurane</article-title>.” <source>Anesthesiology</source><volume>127</volume>: <fpage>976</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1097/ALN.0000000000001888</pub-id>.<pub-id pub-id-type="pmid">28938276</pub-id><pub-id pub-id-type="pmcid">PMC5685871</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0002"><mixed-citation publication-type="journal" id="hbm70171-cit-0002"><string-name name-style="western"><surname>Brown</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Benveniste</surname></string-name>, <string-name name-style="western"><given-names>S. E.</given-names><surname>Black</surname></string-name>, et al. <year>2018</year>. “<article-title>Understanding the Role of the Perivascular Space in Cerebral Small Vessel Disease</article-title>.” <source>Cardiovascular Research</source><volume>114</volume>: <fpage>1462</fpage>–<lpage>1473</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvy113</pub-id>.<pub-id pub-id-type="pmid">29726891</pub-id><pub-id pub-id-type="pmcid">PMC6455920</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0003"><mixed-citation publication-type="journal" id="hbm70171-cit-0003"><string-name name-style="western"><surname>Burfeind</surname>, <given-names>K. G.</given-names></string-name>, <string-name name-style="western"><given-names>C. F.</given-names><surname>Murchison</surname></string-name>, <string-name name-style="western"><given-names>S. K.</given-names><surname>Westaway</surname></string-name>, et al. <year>2017</year>. “<article-title>The Effects of Noncoding Aquaporin‐4 Single‐Nucleotide Polymorphisms on Cognition and Functional Progression of Alzheimer's Disease</article-title>.” <source>A&amp;D Transl Res &amp; Clin Interv</source><volume>3</volume>: <fpage>348</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.trci.2017.05.001</pub-id>.<pub-id pub-id-type="pmcid">PMC5651426</pub-id><pub-id pub-id-type="pmid">29067342</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0004"><mixed-citation publication-type="journal" id="hbm70171-cit-0004"><string-name name-style="western"><surname>Chandra</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Farrell</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Wilson</surname></string-name>, et al. <year>2021</year>. “<article-title>Aquaporin‐4 Polymorphisms Predict Amyloid Burden and Clinical Outcome in the Alzheimer's Disease Spectrum</article-title>.” <source>Neurobiology of Aging</source><volume>97</volume>: <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2020.06.007</pub-id>.<pub-id pub-id-type="pmid">33068891</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0005"><mixed-citation publication-type="journal" id="hbm70171-cit-0005"><string-name name-style="western"><surname>Dikmen</surname>, <given-names>S. S.</given-names></string-name>, <string-name name-style="western"><given-names>R. K.</given-names><surname>Heaton</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Grant</surname></string-name>, and <string-name name-style="western"><given-names>N. R.</given-names><surname>Temkin</surname></string-name>. <year>1999</year>. “<article-title>Test‐Retest Reliability and Practice Effects of Expanded Halstead‐Reitan Neuropsychological Test Battery</article-title>.” <source>Journal of the International Neuropsychological Society</source><volume>5</volume>: <fpage>346</fpage>–<lpage>356</lpage>.<pub-id pub-id-type="pmid">10349297</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0006"><mixed-citation publication-type="journal" id="hbm70171-cit-0006"><string-name name-style="western"><surname>Duering</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Finsterwalder</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Baykara</surname></string-name>, et al. <year>2018</year>. “<article-title>Free Water Determines Diffusion Alterations and Clinical Status in Cerebral Small Vessel Disease</article-title>.” <source>Alzheimers Dement</source><volume>14</volume>: <fpage>764</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2017.12.007</pub-id>.<pub-id pub-id-type="pmid">29406155</pub-id><pub-id pub-id-type="pmcid">PMC5994358</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0007"><mixed-citation publication-type="journal" id="hbm70171-cit-0007"><string-name name-style="western"><surname>Fang</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Dai</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Jin</surname></string-name>, et al. <year>2022</year>. “<article-title>Aquaporin‐4 Polymorphisms Are Associated With Cognitive Performance in Parkinson's Disease</article-title>.” <source>Frontiers in Aging Neuroscience</source><volume>13</volume>: <elocation-id>740491</elocation-id>. <pub-id pub-id-type="doi">10.3389/fnagi.2021.740491</pub-id>.<pub-id pub-id-type="pmid">35356146</pub-id><pub-id pub-id-type="pmcid">PMC8959914</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0008"><mixed-citation publication-type="journal" id="hbm70171-cit-0008"><string-name name-style="western"><surname>Fortin</surname>, <given-names>J.‐P.</given-names></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Parker</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Tunç</surname></string-name>, et al. <year>2017</year>. “<article-title>Harmonization of Multi‐Site Diffusion Tensor Imaging Data</article-title>.” <source>NeuroImage</source><volume>161</volume>: <fpage>149</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.08.047</pub-id>.<pub-id pub-id-type="pmid">28826946</pub-id><pub-id pub-id-type="pmcid">PMC5736019</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0009"><mixed-citation publication-type="journal" id="hbm70171-cit-0009"><string-name name-style="western"><surname>Gomolka</surname>, <given-names>R. S.</given-names></string-name>, <string-name name-style="western"><given-names>L. M.</given-names><surname>Hablitz</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Mestre</surname></string-name>, et al. <year>2023</year>. “<article-title>Loss of Aquaporin‐4 Results in Glymphatic System Dysfunction via Brain‐Wide Interstitial Fluid Stagnation</article-title>.” <source>eLife</source><volume>12</volume>: <elocation-id>e82232</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.82232</pub-id>.<pub-id pub-id-type="pmid">36757363</pub-id><pub-id pub-id-type="pmcid">PMC9995113</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0010"><mixed-citation publication-type="journal" id="hbm70171-cit-0010"><string-name name-style="western"><surname>Hill</surname>, <given-names>W. G.</given-names></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Robertson</surname></string-name>. <year>1968</year>. “<article-title>Linkage Disequilibrium in Finite Populations</article-title>.” <source>Theoretical and Applied Genetics</source><volume>38</volume>: <fpage>226</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1007/BF01245622</pub-id>.<pub-id pub-id-type="pmid">24442307</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0011"><mixed-citation publication-type="journal" id="hbm70171-cit-0011"><string-name name-style="western"><surname>Hong</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Hong</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Luo</surname></string-name>, et al. <year>2024</year>. “<article-title>The Relationship Between Amyloid Pathology, Cerebral Small Vessel Disease, Glymphatic Dysfunction, and Cognition: A Study Based on Alzheimer's Disease Continuum Participants</article-title>.” <source>Alzheimer's Research &amp; Therapy</source><volume>16</volume>: <fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-024-01407-w</pub-id>.<pub-id pub-id-type="pmcid">PMC10877805</pub-id><pub-id pub-id-type="pmid">38378607</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0012"><mixed-citation publication-type="journal" id="hbm70171-cit-0012"><string-name name-style="western"><surname>Hook‐Barnard</surname>, <given-names>I. G.</given-names></string-name>, and <string-name name-style="western"><given-names>D. M.</given-names><surname>Hinton</surname></string-name>. <year>2007</year>. “<article-title>Transcription Initiation by Mix and Match Elements: Flexibility for Polymerase Binding to Bacterial Promoters</article-title>.” <source>Gene Regulation and Systems Biology</source><volume>1</volume>: <fpage>275</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1177/117762500700100020</pub-id>.<pub-id pub-id-type="pmid">19119427</pub-id><pub-id pub-id-type="pmcid">PMC2613000</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0013"><mixed-citation publication-type="journal" id="hbm70171-cit-0013"><string-name name-style="western"><surname>Hosking</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Lumsden</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Lewis</surname></string-name>, et al. <year>2004</year>. “<article-title>Detection of Genotyping Errors by Hardy‐Weinberg Equilibrium Testing</article-title>.” <source>European Journal of Human Genetics</source><volume>12</volume>: <fpage>395</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201164</pub-id>.<pub-id pub-id-type="pmid">14872201</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0014"><mixed-citation publication-type="journal" id="hbm70171-cit-0014"><string-name name-style="western"><surname>Huang</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Zhang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Jiaerken</surname></string-name>, et al. <year>2022</year>. “<article-title>White Matter Free Water Is a Composite Marker of Cerebral Small Vessel Degeneration</article-title>.” <source>Translational Stroke Research</source><volume>13</volume>: <fpage>56</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s12975-021-00899-0</pub-id>.<pub-id pub-id-type="pmid">33634379</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0015"><mixed-citation publication-type="journal" id="hbm70171-cit-0015"><string-name name-style="western"><surname>Huang</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><given-names>Y.‐R.</given-names><surname>Zhang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Guo</surname></string-name>, et al. <year>2024</year>. “<article-title>Glymphatic System Dysfunction Predicts Amyloid Deposition, Neurodegeneration, and Clinical Progression in Alzheimer's Disease</article-title>.” <source>Alzheimer's &amp; Dementia</source><volume>20</volume>, no. <issue>5</issue>: <elocation-id>alz.13789</elocation-id>. <pub-id pub-id-type="doi">10.1002/alz.13789</pub-id>.<pub-id pub-id-type="pmcid">PMC11095446</pub-id><pub-id pub-id-type="pmid">38501315</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0016"><mixed-citation publication-type="journal" id="hbm70171-cit-0016"><string-name name-style="western"><surname>Iliff</surname>, <given-names>J. J.</given-names></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Liao</surname></string-name>, et al. <year>2012</year>. “<article-title>A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β</article-title>.” <source>Science Translational Medicine</source><volume>4</volume>: <fpage>147ra111</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3003748</pub-id>.<pub-id pub-id-type="pmcid">PMC3551275</pub-id><pub-id pub-id-type="pmid">22896675</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0017"><mixed-citation publication-type="journal" id="hbm70171-cit-0017"><string-name name-style="western"><surname>Ishida</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Yamada</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Nishiyama</surname></string-name>, et al. <year>2022</year>. “<article-title>Glymphatic System Clears Extracellular Tau and Protects From Tau Aggregation and Neurodegeneration</article-title>.” <source>Journal of Experimental Medicine</source><volume>219</volume>: <elocation-id>e20211275</elocation-id>. <pub-id pub-id-type="doi">10.1084/jem.20211275</pub-id>.<pub-id pub-id-type="pmid">35212707</pub-id><pub-id pub-id-type="pmcid">PMC8932543</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0018"><mixed-citation publication-type="journal" id="hbm70171-cit-0018"><string-name name-style="western"><surname>Kamagata</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Andica</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Takabayashi</surname></string-name>, et al. <year>2022</year>. “<article-title>Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease</article-title>.” <source>Neurology</source><volume>99</volume>: <fpage>e2648</fpage>–<lpage>e2660</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000201300</pub-id>.<pub-id pub-id-type="pmid">36123122</pub-id><pub-id pub-id-type="pmcid">PMC9757870</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0019"><mixed-citation publication-type="journal" id="hbm70171-cit-0019"><string-name name-style="western"><surname>Keshavan</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Pannee</surname></string-name>, <string-name name-style="western"><given-names>T. K.</given-names><surname>Karikari</surname></string-name>, et al. <year>2021</year>. “<article-title>Population‐Based Blood Screening for Preclinical Alzheimer's Disease in a British Birth Cohort at Age 70</article-title>.” <source>Brain</source><volume>144</volume>: <fpage>434</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awaa403</pub-id>.<pub-id pub-id-type="pmid">33479777</pub-id><pub-id pub-id-type="pmcid">PMC7940173</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0020"><mixed-citation publication-type="journal" id="hbm70171-cit-0020"><string-name name-style="western"><surname>Kleffner</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Bungeroth</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Schiffbauer</surname></string-name>, <string-name name-style="western"><given-names>W. R.</given-names><surname>Schäbitz</surname></string-name>, <string-name name-style="western"><given-names>E. B.</given-names><surname>Ringelstein</surname></string-name>, and <string-name name-style="western"><given-names>G.</given-names><surname>Kuhlenbäumer</surname></string-name>. <year>2008</year>. “<article-title>The Role of Aquaporin‐4 Polymorphisms in the Development of Brain Edema After Middle Cerebral Artery Occlusion</article-title>.” <source>Stroke</source><volume>39</volume>: <fpage>1333</fpage>–<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.500785</pub-id>.<pub-id pub-id-type="pmid">18309154</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0021"><mixed-citation publication-type="journal" id="hbm70171-cit-0021"><string-name name-style="western"><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Luo</surname></string-name>, et al. <year>2023</year>. “<article-title>Associations of Alzheimer's Disease Pathology and Small Vessel Disease With Cerebral White Matter Degeneration: A Tract‐Based MR Diffusion Imaging Study</article-title>.” <source>Journal of Magnetic Resonance Imaging</source><volume>60</volume>, no. <issue>1</issue>: <fpage>268</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1002/jmri.29022</pub-id>.<pub-id pub-id-type="pmid">37737474</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0022"><mixed-citation publication-type="journal" id="hbm70171-cit-0022"><string-name name-style="western"><surname>Maillard</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><given-names>G. F.</given-names><surname>Mitchell</surname></string-name>, <string-name name-style="western"><given-names>J. J.</given-names><surname>Himali</surname></string-name>, et al. <year>2017</year>. “<article-title>Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury</article-title>.” <source>Stroke</source><volume>48</volume>: <fpage>1567</fpage>–<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.116.016321</pub-id>.<pub-id pub-id-type="pmid">28473633</pub-id><pub-id pub-id-type="pmcid">PMC5502744</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0023"><mixed-citation publication-type="journal" id="hbm70171-cit-0023"><string-name name-style="western"><surname>Mestre</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><given-names>L. M.</given-names><surname>Hablitz</surname></string-name>, <string-name name-style="western"><given-names>A. L.</given-names><surname>Xavier</surname></string-name>, et al. <year>2018</year>. “<article-title>Aquaporin‐4‐Dependent Glymphatic Solute Transport in the Rodent Brain</article-title>.” <volume>7</volume>: <elocation-id>e40070</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.40070</pub-id>.<pub-id pub-id-type="pmcid">PMC6307855</pub-id><pub-id pub-id-type="pmid">30561329</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0024"><mixed-citation publication-type="journal" id="hbm70171-cit-0024"><string-name name-style="western"><surname>Nagelhus</surname>, <given-names>E. A.</given-names></string-name>, and <string-name name-style="western"><given-names>O. P.</given-names><surname>Ottersen</surname></string-name>. <year>2013</year>. “<article-title>Physiological Roles of Aquaporin‐4 in Brain</article-title>.” <source>Physiological Reviews</source><volume>93</volume>: <fpage>1543</fpage>–<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00011.2013</pub-id>.<pub-id pub-id-type="pmid">24137016</pub-id><pub-id pub-id-type="pmcid">PMC3858210</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0025"><mixed-citation publication-type="journal" id="hbm70171-cit-0025"><string-name name-style="western"><surname>Nedergaard</surname>, <given-names>M.</given-names></string-name><year>2013</year>. “<article-title>Garbage Truck of the Brain</article-title>.” <source>Science</source><volume>340</volume>: <fpage>1529</fpage>–<lpage>1530</lpage>. <pub-id pub-id-type="doi">10.1126/science.1240514</pub-id>.<pub-id pub-id-type="pmid">23812703</pub-id><pub-id pub-id-type="pmcid">PMC3749839</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0026"><mixed-citation publication-type="journal" id="hbm70171-cit-0026"><string-name name-style="western"><surname>Nedergaard</surname>, <given-names>M.</given-names></string-name>, and <string-name name-style="western"><given-names>S. A.</given-names><surname>Goldman</surname></string-name>. <year>2020</year>. “<article-title>Glymphatic Failure as a Final Common Pathway to Dementia</article-title>.” <source>Science</source><volume>370</volume>: <fpage>50</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb8739</pub-id>.<pub-id pub-id-type="pmid">33004510</pub-id><pub-id pub-id-type="pmcid">PMC8186542</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0027"><mixed-citation publication-type="journal" id="hbm70171-cit-0027"><string-name name-style="western"><surname>Oh</surname>, <given-names>E. S.</given-names></string-name>, <string-name name-style="western"><given-names>P. B.</given-names><surname>Rosenberg</surname></string-name>, <string-name name-style="western"><given-names>G. B.</given-names><surname>Rattinger</surname></string-name>, <string-name name-style="western"><given-names>E. A.</given-names><surname>Stuart</surname></string-name>, <string-name name-style="western"><given-names>C. G.</given-names><surname>Lyketsos</surname></string-name>, and <string-name name-style="western"><given-names>J. M. S.</given-names><surname>Leoutsakos</surname></string-name>. <year>2021</year>. “<article-title>Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD)</article-title>.” <source>Journal of the American Geriatrics Society</source><volume>69</volume>: <fpage>955</fpage>–<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1111/jgs.16970</pub-id>.<pub-id pub-id-type="pmid">33382921</pub-id><pub-id pub-id-type="pmcid">PMC8675538</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0028"><mixed-citation publication-type="journal" id="hbm70171-cit-0028"><string-name name-style="western"><surname>Pasternak</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Sochen</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Gur</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Intrator</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Assaf</surname></string-name>. <year>2009</year>. “<article-title>Free Water Elimination and Mapping From Diffusion MRI</article-title>.” <source>Magnetic Resonance in Medicine</source><volume>62</volume>: <fpage>717</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.22055</pub-id>.<pub-id pub-id-type="pmid">19623619</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0029"><mixed-citation publication-type="journal" id="hbm70171-cit-0029"><string-name name-style="western"><surname>Perosa</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Oltmer</surname></string-name>, <string-name name-style="western"><given-names>L. P.</given-names><surname>Munting</surname></string-name>, et al. <year>2022</year>. “<article-title>Perivascular Space Dilation Is Associated With Vascular Amyloid‐β Accumulation in the Overlying Cortex</article-title>.” <source>Acta Neuropathologica</source><volume>143</volume>: <fpage>331</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-021-02393-1</pub-id>.<pub-id pub-id-type="pmid">34928427</pub-id><pub-id pub-id-type="pmcid">PMC9047512</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0030"><mixed-citation publication-type="journal" id="hbm70171-cit-0030"><string-name name-style="western"><surname>Purcell</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Neale</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Todd‐Brown</surname></string-name>, et al. <year>2007</year>. “<article-title>PLINK: A Tool Set for Whole‐Genome Association and Population‐Based Linkage Analyses</article-title>.” <source>American Journal of Human Genetics</source><volume>81</volume>: <fpage>559</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1086/519795</pub-id>.<pub-id pub-id-type="pmid">17701901</pub-id><pub-id pub-id-type="pmcid">PMC1950838</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0031"><mixed-citation publication-type="journal" id="hbm70171-cit-0031"><string-name name-style="western"><surname>Rainey‐Smith</surname>, <given-names>S. R.</given-names></string-name>, <string-name name-style="western"><given-names>G. N.</given-names><surname>Mazzucchelli</surname></string-name>, <string-name name-style="western"><given-names>V. L.</given-names><surname>Villemagne</surname></string-name>, et al. <year>2018</year>. “<article-title>Genetic Variation in Aquaporin‐4 Moderates the Relationship Between Sleep and Brain Aβ‐Amyloid Burden</article-title>.” <source>Translational Psychiatry</source><volume>8</volume>: <fpage>47</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-018-0094-x</pub-id>.<pub-id pub-id-type="pmid">29479071</pub-id><pub-id pub-id-type="pmcid">PMC5865132</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0032"><mixed-citation publication-type="journal" id="hbm70171-cit-0032"><string-name name-style="western"><surname>Rasmussen</surname>, <given-names>M. K.</given-names></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Mestre</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Nedergaard</surname></string-name>. <year>2018</year>. “<article-title>The Glymphatic Pathway in Neurological Disorders</article-title>.” <source>Lancet Neurology</source><volume>17</volume>: <fpage>1016</fpage>–<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30318-1</pub-id>.<pub-id pub-id-type="pmid">30353860</pub-id><pub-id pub-id-type="pmcid">PMC6261373</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0033"><mixed-citation publication-type="journal" id="hbm70171-cit-0033"><string-name name-style="western"><surname>Royse</surname>, <given-names>S. K.</given-names></string-name>, <string-name name-style="western"><given-names>D. S.</given-names><surname>Minhas</surname></string-name>, <string-name name-style="western"><given-names>B. J.</given-names><surname>Lopresti</surname></string-name>, et al. <year>2021</year>. “<article-title>Validation of Amyloid PET Positivity Thresholds in Centiloids: A Multisite PET Study Approach</article-title>.” <source>Alzheimer's Research &amp; Therapy</source><volume>13</volume>: <fpage>99</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-021-00836-1</pub-id>.<pub-id pub-id-type="pmcid">PMC8111744</pub-id><pub-id pub-id-type="pmid">33971965</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0034"><mixed-citation publication-type="journal" id="hbm70171-cit-0034"><string-name name-style="western"><surname>Saadoun</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><given-names>M. C.</given-names><surname>Papadopoulos</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Watanabe</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Yan</surname></string-name>, <string-name name-style="western"><given-names>G. T.</given-names><surname>Manley</surname></string-name>, and <string-name name-style="western"><given-names>A. S.</given-names><surname>Verkman</surname></string-name>. <year>2005</year>. “<article-title>Involvement of Aquaporin‐4 in Astroglial Cell Migration and Glial Scar Formation</article-title>.” <source>Journal of Cell Science</source><volume>118</volume>: <fpage>5691</fpage>–<lpage>5698</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02680</pub-id>.<pub-id pub-id-type="pmid">16303850</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0035"><mixed-citation publication-type="journal" id="hbm70171-cit-0035"><string-name name-style="western"><surname>Smith</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western"><given-names>B. J.</given-names><surname>Jin</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Ratelade</surname></string-name>, and <string-name name-style="western"><given-names>A. S.</given-names><surname>Verkman</surname></string-name>. <year>2014</year>. “<article-title>Aggregation State Determines the Localization and Function of M1‐ and M23‐Aquaporin‐4 in Astrocytes</article-title>.” <source>Journal of Cell Biology</source><volume>204</volume>: <fpage>559</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201308118</pub-id>.<pub-id pub-id-type="pmid">24515349</pub-id><pub-id pub-id-type="pmcid">PMC3926963</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0036"><mixed-citation publication-type="journal" id="hbm70171-cit-0036"><string-name name-style="western"><surname>Tabangin</surname>, <given-names>M. E.</given-names></string-name>, <string-name name-style="western"><given-names>J. G.</given-names><surname>Woo</surname></string-name>, and <string-name name-style="western"><given-names>L. J.</given-names><surname>Martin</surname></string-name>. <year>2009</year>. “<article-title>The Effect of Minor Allele Frequency on the Likelihood of Obtaining False Positives</article-title>.” <source>BMC Proceedings</source><volume>3</volume>, no. <issue>Suppl 7</issue>: <elocation-id>S41</elocation-id>. <pub-id pub-id-type="doi">10.1186/1753-6561-3-S7-S41</pub-id>.<pub-id pub-id-type="pmid">20018033</pub-id><pub-id pub-id-type="pmcid">PMC2795940</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0037"><mixed-citation publication-type="journal" id="hbm70171-cit-0037"><string-name name-style="western"><surname>Taoka</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Masutani</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Kawai</surname></string-name>, et al. <year>2017</year>. “<article-title>Evaluation of Glymphatic System Activity With the Diffusion MR Technique: Diffusion Tensor Image Analysis Along the Perivascular Space (DTI‐ALPS) in Alzheimer's Disease Cases</article-title>.” <source>Japanese Journal of Radiology</source><volume>35</volume>: <fpage>172</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1007/s11604-017-0617-z</pub-id>.<pub-id pub-id-type="pmid">28197821</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0038"><mixed-citation publication-type="journal" id="hbm70171-cit-0038"><string-name name-style="western"><surname>Tedeschi Dauar</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><given-names>T. A.</given-names><surname>Pascoal</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Therriault</surname></string-name>, et al. <year>2023</year>. “<article-title>Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance Within the Clinical Spectrum of Alzheimer's Disease</article-title>.” <source>Brain Sciences</source><volume>13</volume>: <elocation-id>232</elocation-id>. <pub-id pub-id-type="doi">10.3390/brainsci13020232</pub-id>.<pub-id pub-id-type="pmid">36831775</pub-id><pub-id pub-id-type="pmcid">PMC9954101</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0039"><mixed-citation publication-type="journal" id="hbm70171-cit-0039"><string-name name-style="western"><surname>Tiwari</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Atluri</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Kaushik</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Yndart</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Nair</surname></string-name>. <year>2019</year>. “<article-title>Alzheimer's Disease: Pathogenesis, Diagnostics, and Therapeutics</article-title>.” <volume>14</volume>: <fpage>5541</fpage>–<lpage>5554</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S200490</pub-id>.<pub-id pub-id-type="pmcid">PMC6650620</pub-id><pub-id pub-id-type="pmid">31410002</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0040"><mixed-citation publication-type="journal" id="hbm70171-cit-0040"><string-name name-style="western"><surname>Tsang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><given-names>J. F.</given-names><surname>Fullard</surname></string-name>, <string-name name-style="western"><given-names>S. G.</given-names><surname>Giakoumaki</surname></string-name>, et al. <year>2015</year>. “<article-title>The Relationship Between Dopamine Receptor D1 and Cognitive Performance</article-title>.” <source>NPJ Schizophrenia</source><volume>1</volume>: <elocation-id>14002</elocation-id>. <pub-id pub-id-type="doi">10.1038/npjschz.2014.2</pub-id>.<pub-id pub-id-type="pmid">27336024</pub-id><pub-id pub-id-type="pmcid">PMC4849437</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0041"><mixed-citation publication-type="journal" id="hbm70171-cit-0041"><string-name name-style="western"><surname>Verkman</surname>, <given-names>A. S.</given-names></string-name><year>2012</year>. “<article-title>Aquaporins in Clinical Medicine</article-title>.” <source>Annual Review of Medicine</source><volume>63</volume>: <fpage>303</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-med-043010-193843</pub-id>.<pub-id pub-id-type="pmcid">PMC3319404</pub-id><pub-id pub-id-type="pmid">22248325</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0042"><mixed-citation publication-type="journal" id="hbm70171-cit-0042"><string-name name-style="western"><surname>Vittorini</surname>, <given-names>M. G.</given-names></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Sahin</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Trojan</surname></string-name>, et al. <year>2024</year>. “<article-title>The Glymphatic System in Migraine and Other Headaches</article-title>.” <source>Journal of Headache and Pain</source><volume>25</volume>: <fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/s10194-024-01741-2</pub-id>.<pub-id pub-id-type="pmid">38462633</pub-id><pub-id pub-id-type="pmcid">PMC10926631</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0043"><mixed-citation publication-type="journal" id="hbm70171-cit-0043"><string-name name-style="western"><surname>Zeng</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Luo</surname></string-name>, et al. <year>2022</year>. “<article-title>The Association of Enlarged Perivascular Space With Microglia‐Related Inflammation and Alzheimer's Pathology in Cognitively Normal Elderly</article-title>.” <source>Neurobiology of Disease</source><volume>170</volume>: <elocation-id>105755</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.nbd.2022.105755</pub-id>.<pub-id pub-id-type="pmid">35577066</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0044"><mixed-citation publication-type="journal" id="hbm70171-cit-0044"><string-name name-style="western"><surname>Zeppenfeld</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Simon</surname></string-name>, <string-name name-style="western"><given-names>J. D.</given-names><surname>Haswell</surname></string-name>, et al. <year>2017</year>. “<article-title>Association of Perivascular Localization of Aquaporin‐4 With Cognition and Alzheimer Disease in Aging Brains</article-title>.” <source>JAMA Neurology</source><volume>74</volume>: <fpage>91</fpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.4370</pub-id>.<pub-id pub-id-type="pmid">27893874</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0045"><mixed-citation publication-type="journal" id="hbm70171-cit-0045"><string-name name-style="western"><surname>Zhang</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Huang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Jiaerken</surname></string-name>, et al. <year>2021a</year>. “<article-title>Venous Disruption Affects White Matter Integrity Through Increased Interstitial Fluid in Cerebral Small Vessel Disease</article-title>.” <source>Journal of Cerebral Blood Flow and Metabolism</source><volume>41</volume>: <fpage>157</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X20904840</pub-id>.<pub-id pub-id-type="pmid">32065078</pub-id><pub-id pub-id-type="pmcid">PMC7747165</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0046"><mixed-citation publication-type="journal" id="hbm70171-cit-0046"><string-name name-style="western"><surname>Zhang</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Zhou</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Wang</surname></string-name>, et al. <year>2021b</year>. “<article-title>Glymphatic Clearance Function in Patients With Cerebral Small Vessel Disease</article-title>.” <source>NeuroImage</source><volume>238</volume>: <elocation-id>118257</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2021.118257</pub-id>.<pub-id pub-id-type="pmid">34118396</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0047"><mixed-citation publication-type="journal" id="hbm70171-cit-0047"><string-name name-style="western"><surname>Zhu</surname>, <given-names>Y.‐C.</given-names></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Dufouil</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Mazoyer</surname></string-name>, et al. <year>2011</year>. “<article-title>Frequency and Location of Dilated Virchow‐Robin Spaces in Elderly People: A Population‐Based 3D MR Imaging Study</article-title>.” <source>AJNR. American Journal of Neuroradiology</source><volume>32</volume>: <fpage>709</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A2366</pub-id>.<pub-id pub-id-type="pmid">21349956</pub-id><pub-id pub-id-type="pmcid">PMC7965873</pub-id></mixed-citation></ref><ref id="hbm70171-bib-0048"><mixed-citation publication-type="journal" id="hbm70171-cit-0048"><string-name name-style="western"><surname>Zhu</surname>, <given-names>Z.</given-names></string-name>, <string-name name-style="western"><given-names>Q.</given-names><surname>Zeng</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Zhan</surname></string-name>, et al. <year>2022</year>. “<article-title>White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons With Mild Cognitive Impairment</article-title>.” <source>JAD</source><volume>86</volume>: <fpage>741</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-215541</pub-id>.<pub-id pub-id-type="pmid">35124653</pub-id></mixed-citation></ref></ref-list></back></article>